Postprocedural endocrine and metabolic disorders, not elsewhere classified

E4_ENDOMETPOSTOP

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E89 Hospital discharge: ICD-9 — 2440\|2513\|2562\|2572\|24409 Cause of death: ICD-10 — E89 Cause of death: ICD-9 — 2440\|2513\|2562\|2572\|24409 KELA reimbursements: KELA codes — ANY KELA reimbursements: ICD-10 — E89.4, E89.5 3 out of 7 registries used, show all original rules.	5229
4. Check minimum number of events None	5229
5. Include endpoints None	5229
6. Filter based on genotype QC (FinnGen only)	5229

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E70-E90
Name in latin: Perturbationes endocrinae et metabolicae post interventiones non alibi classificatae

NAME	E4_ENDOMETPOSTOP
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E89
HD_ICD_9	2440\|2513\|2562\|2572\|24409
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E89
COD_ICD_9	2440\|2513\|2562\|2572\|24409
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	ANY
KELA_REIMB_ICD	E894\|E895
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Postprocedural endocrine and metabolic disorders, not elsewhere classified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Hypopituitarism after medical therapy

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	24717	19645	4902
Only index persons	22223	17885	4338
Unadjusted period prevalence (%)
Whole population	0.48	0.56	0.14
Only index persons	0.56	0.66	0.17
Median age at first event (years)
Whole population	58.32	58.68	56.98
Only index persons	56.84	57.02	56.09

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5229	4251	978
Unadjusted period prevalence (%)	1.26	1.45	0.43
Median age at first event (years)	52.31	51.34	56.52

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4613: Matched controls
46129

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

50.7

323.0

731

171

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

2471.5

323.0

468

104

Kela drug reimbursment

Thyroid insufficiency

23.2

323.0

2155

1676

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

27.2

323.0

960

442

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

448.7

323.0

2007

H03BB01

ATC

carbimazole; oral

34.2

323.0

1628

723

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

38.3

323.0

1368

502

BAA60

NOMESCO Finland

Total thyroidectomy

69.2

323.0

1559

337

H03AA01

ATC

levothyroxine sodium; systemic

20.7

323.0

3680

7396

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

40.1

323.0

463

128

A11CC03

ATC

alfacalcidol; systemic

28.8

323.0

457

175

121

Kela drug reimbursment

Severe hypofunction of sexual glands

34.2

323.0

860

307

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

1167.1

323.0

1145

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

45.8

323.0

601

150

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.5

323.0

2257

9979

EP1AE

NOMESCO Finland

Neck ultrasound examination

9.1

323.0

853

1116

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

447.1

297.6

295

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

9.3

281.1

622

761

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

27.2

274.7

385

154

106

Kela drug reimbursment

Hypoparathyroidism

176.1

239.6

250

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

19.6

233.3

362

199

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

3.9

209.1

1011

3120

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

49.7

208.5

254

E83.51

ICD-10 Finland

Hypocalcemia

245.5

206.5

211

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

40.7

186.3

236

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

8.8

163.5

368

450

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

19.1

155.2

242

133

4CJ01

NOMESCO Finland

91.2

150.2

167

WX408

NOMESCO Finland

General anesthesy, balanced

2.5

146.1

1506

7497

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

12.8

144.2

265

219

A11CC02

ATC

dihydrotachysterol; oral

131.8

143.0

153

C07AA05

ATC

propranolol; systemic

2.6

141.9

1280

5899

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

8.9

140.8

313

373

A12AA04

ATC

calcium carbonate; oral

19.1

132.9

207

113

ZX114

NOMESCO Finland

Intramuscular

11.2

130.8

256

241

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

10.4

128.2

261

265

H02AB09

ATC

hydrocortisone; systemic

9.4

127.3

273

305

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.5

126.5

1277

6195

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

55.8

122.6

146

E03.89

ICD-10 Finland

Other specified hypothyroidism

5.9

120.2

356

642

C07AB07

ATC

bisoprolol; oral

2.1

118.2

1983

12134

E89.0

ICD-10 Finland

Postprocedural hypothyroidism

126.3

114.6

123

T86

ICPC

Hypothyroidism/myxoedema

4.8

112.8

402

895

E89.4

ICD-10 Finland

Postprocedural ovarian failure

529.7

105.1

104

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

8.9

104.3

230

269

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

3.3

99.0

553

1826

BA1NN

NOMESCO Finland

I-131 dose capsel measurement

76.6

98.7

112

E03

ICD-10 Finland

Other hypothyroidism

3.6

97.4

473

1400

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

96.2

1854

11696

ZXA10

NOMESCO Finland

Bilateral

2.3

93.4

996

4850

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

8.2

90.0

209

266

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

28.4

88.9

122

H06.2

ICD-10 Finland

Dysthyroid exophthalmos

64.5

86.9

101

WX402

NOMESCO Finland

General anaesthesia

2.3

86.2

918

4449

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

5.4

82.6

263

514

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

802.0

80.7

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

42.5

76.9

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

31.6

76.5

102

N02BE01

ATC

paracetamol; systemic, rectal

2.1

76.1

3964

34233

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

5.4

76.0

242

472

127

Kela drug reimbursment

Transplant complication

10.4

74.4

150

149

T85

ICPC

Hyperthyroidism/thyrotoxicosis

17.6

73.5

117

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

72.7

949

5001

2440A

ICD-9 Finland

Acquired hypothyroidism, Postsurgical hypothyroidism

+∞

72.1

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

33.1

69.1

N80.1

ICD-10 Finland

Endometriosis of ovary

4.2

68.9

278

694

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

16.1

68.1

112

H062, E050

ICD-10 Finland

58.1

67.9

TPH07

NOMESCO Finland

Cathetrisation of artery

2.8

67.7

466

1753

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

8.2

64.4

148

185

E89.6

ICD-10 Finland

Postprocedural adrenocortical(-medullary) hypofunction

+∞

63.7

E05.1

ICD-10 Finland

Thyrotoxicosis with toxic single thyroid nodule

34.8

63.0

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.5

61.5

190

358

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

16.4

60.1

T71

ICPC

Malignant neoplasm thyroid

75.6

59.2

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

6.2

59.0

164

271

E89.30

ICD-10 Finland

Postprocedural hypopituitarism

+∞

58.4

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

57.6

1916

13730

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.9

57.5

251

672

101

Kela drug reimbursment

Anterior pituitary hypofunction

20.4

57.1

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

24.2

56.8

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

16.9

56.5

XW000

NOMESCO Finland

Bone marrow biopsy

4.2

56.1

226

563

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

3.9

56.0

247

667

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

55.9

549

2511

E83.50

ICD-10 Finland

Hypercalcemia

19.9

55.3

E89.9

ICD-10 Finland

Postprocedural endocrine and metabolic disorder, unspecified

+∞

55.3

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

54.8

990

5839

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.6

53.3

2263

17201

A02BC02

ATC

pantoprazole; systemic

1.6

53.2

2837

22874

LCD00

NOMESCO Finland

Hysterectomy

3.0

53.0

331

1164

E20.8

ICD-10 Finland

Other hypoparathyroidism

85.4

53.0

H02AB06

ATC

prednisolone; systemic

1.6

52.9

2054

15231

E87.6

ICD-10 Finland

Hypokalaemia

10.5

52.4

104

101

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

49.1

52.1

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.0

51.9

320

1116

C03CA01

ATC

furosemide; systemic

1.9

51.0

940

5565

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

49.2

1192

7701

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

49.0

2043

15328

E04.1

ICD-10 Finland

Nontoxic single thyroid nodule

5.1

48.8

159

319

B01AB05

ATC

enoxaparin; parenteral

1.7

47.8

1293

8618

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

9.8

47.1

101

ZX120

NOMESCO Finland

Intravenous

2.4

47.1

453

2039

WW306

NOMESCO Finland

Transfer of stem cells from foreign registered donator

60.7

46.3

E05.80

ICD-10 Finland

Subacute thyrotoxicosis

9.2

46.1

108

E21.0

ICD-10 Finland

Primary hyperparathyroidism

6.2

46.1

127

208

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

17.2

45.9

8341/3-C73.9

ICD-O-3

Papillary microcarcinoma of thyroid gland

101.1

45.8

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.6

45.5

215

615

Z51.88

ICD-10 Finland

Other specified medical care

5.9

45.5

132

231

C08CA01

ATC

amlodipine; oral

1.7

45.4

1230

8174

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

8.5

45.3

101

121

A12AA06

ATC

calcium lactate gluconate; oral

73.8

45.0

WW200

NOMESCO Finland

Immunization

4.3

44.9

172

408

N02AX02

ATC

tramadol; systemic, rectal

1.6

44.3

1725

12618

C07AB02

ATC

metoprolol; systemic

1.9

44.1

756

4339

E23.00

ICD-10 Finland

Panhypopituitarism

23.6

44.0

R4110

NOMESCO Finland

Physiotherapy

1.7

43.9

1120

7305

WX704

NOMESCO Finland

Intubation

2.4

42.5

375

1613

N80.4

ICD-10 Finland

Endometriosis of rectovaginal septum and vagina

6.1

42.4

119

200

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

41.9

487

2392

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

41.5

550

2857

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

42.9

41.3

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.4

40.6

357

1531

ZXA00

NOMESCO Finland

Right side

1.7

40.5

1096

7243

WZC30

NOMESCO Finland

Teaching

2.0

39.9

568

3033

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

39.8

639

3570

A05AA02

ATC

ursodeoxycholic acid; oral

4.7

39.5

138

299

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.9

38.9

246

870

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

38.5

1438

10315

P01AB01

ATC

metronidazole; oral, rectal

1.5

37.4

1819

13856

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

36.6

685

4027

R50.9

ICD-10 Finland

Fever, unspecified

1.9

36.5

576

3192

L04AD01

ATC

ciclosporin; systemic

4.6

35.8

129

289

H01AC01

ATC

somatropin; parenteral

48.2

35.6

A10AE04

ATC

insulin glargine; parenteral

2.4

35.6

319

1380

8330/3-C73.9

ICD-O-3

Follicular carcinoma, NOS, of thyroid gland

26.9

35.0

N73.6

ICD-10 Finland

Female pelvic peritoneal adhesions

5.4

34.9

107

201

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.1

34.8

162

105

Kela drug reimbursment

Adrenal cortical hypofunction

23.0

34.8

BAA25

NOMESCO Finland

Bilateral partial excision of thyroid gland

20.2

34.8

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

34.3

1551

11554

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.6

34.3

272

1103

E86

ICD-10 Finland

Volume depletion

29.0

34.2

UJF32

NOMESCO Finland

Coloscopy

1.6

33.4

1002

6755

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

33.2

563

3194

J01DB01

ATC

cefalexin; oral

1.5

33.1

3610

32259

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

33.0

396

1964

R53

ICD-10 Finland

Malaise and fatigue

1.7

33.0

829

5319

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

3.0

32.8

199

684

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

6.7

32.3

128

E89.5

ICD-10 Finland

Postprocedural testicular hypofunction

+∞

32.3

2506

FHL

Thyroidectomy

20.2

32.1

N02AA05

ATC

oxycodone; systemic

1.9

32.0

510

2827

LAF00

NOMESCO Finland

Unilateral salpingo-oophorectomy

4.7

31.8

110

237

R06.0

ICD-10 Finland

Dyspnoea

1.6

31.6

926

6194

2505

FHL

Bilateral resection (also used if total removal has been performed on the other side)

7.2

31.4

108

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

14.5

31.4

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

5.4

31.3

181

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.6

31.2

233

913

WW500

NOMESCO Finland

Blood transfusion

3.0

31.0

185

630

JN4BD

NOMESCO Finland

Extensive body CT

2.0

30.8

420

2194

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

30.7

705

4401

A02BC05

ATC

esomeprazole; systemic

1.5

30.7

1720

13329

C10AA05

ATC

atorvastatin; oral

1.5

30.7

1140

8076

E20.9

ICD-10 Finland

Hypoparathyroidism, unspecified

35.7

30.5

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

14.7

30.4

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

30.4

672

4148

A02BC01

ATC

omeprazole; systemic

1.6

30.4

1105

7789

AA1AD

NOMESCO Finland

CT of head and brain

1.6

30.1

805

5243

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

30.0

928

6278

N03AX16

ATC

pregabalin; oral

1.6

30.0

961

6565

SPAT1262

SPAT

Handing over of treatment supplies

1.7

29.6

623

3783

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

29.6

284

1273

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

15.6

29.4

WX110

NOMESCO Finland

Local anesthesy

1.4

29.2

2979

25804

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

2.3

29.2

278

1240

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

7.7

29.1

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

29.1

939

6419

N05CF01

ATC

zopiclone; oral

1.5

29.0

1276

9369

C73.94

ICD-10 Finland

Medullary thyroid carcinoma (thyroid)

293.7

28.8

N80.9

ICD-10 Finland

Endometriosis, unspecified

3.7

28.7

131

366

E03.0

ICD-10 Finland

Congenital hypothyroidism with diffuse goitre

8.0

28.5

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

9.9

28.3

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

28.2

314

1505

E05.89

ICD-10 Finland

Other thyrotoxicosis

14.8

28.2

E8901, C7391

ICD-10 Finland

+∞

28.1

H02AA02

ATC

fludrocortisone; oral

8.7

28.1

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

28.0

1402

10565

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

27.6

811

5404

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

27.5

758

4966

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

47.4

27.4

24199

ICD-8 Finland

Non-toxic nodular goitre, Unspecified

5.9

27.4

135

N80.5

ICD-10 Finland

Endometriosis of intestine

9.0

27.4

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

27.3

450

2520

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

5.8

27.1

137

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.1

27.0

156

521

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

27.0

546

3270

L03AA02

ATC

filgrastim; parenteral

3.1

26.7

149

486

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

26.5

459

2612

1930A

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]

20.7

26.5

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

6.0

26.4

126

G47.3

ICD-10 Finland

Sleep apnoea

1.6

26.2

713

4648

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

18.3

26.1

BAA50

NOMESCO Finland

Lobectomy and resection of contralateral lobe of thyroid gland

19.6

26.0

WX892

NOMESCO Finland

Monitored bed care

2.3

26.0

259

1180

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

25.8

662

4246

E05.5

ICD-10 Finland

Thyroid crisis or storm

73.1

25.8

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.2

25.6

261

1201

8340/3-C73.9

ICD-O-3

Papillary carcinoma, follicular variant of thyroid gland

33.2

25.5

N03AX12

ATC

gabapentin; oral

1.7

25.3

619

3918

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.2

25.3

137

438

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

25.3

345

1802

ZXA05

NOMESCO Finland

Left side

1.5

25.3

966

6839

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.1

25.2

310

1550

F64.0

ICD-10 Finland

Transsexualism

20.7

25.1

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

8.0

25.1

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

9.9

24.9

Z71.8

ICD-10 Finland

Other specified counselling

1.5

24.9

975

6937

WX002

NOMESCO Finland

Sedation and analgesia

1.6

24.9

760

5099

L28

ICPC

Limited function/disability (L)

1.7

24.8

538

3285

H02AB04

ATC

methylprednisolone; systemic

1.7

24.5

610

3878

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

24.4

599

3793

N05BA04

ATC

oxazepam; oral

1.5

24.3

1006

7241

19399

ICD-8 Finland

Malignant neoplasm of thyroid gland

48.6

24.3

T90

ICPC

Diabetes non-insulin dependent

1.6

24.1

697

4609

C10AA01

ATC

simvastatin; oral

1.5

24.1

1216

9119

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

13.8

24.0

WX725

NOMESCO Finland

Noninvasive ventilation

2.4

23.9

213

918

H03BA02

ATC

propylthiouracil; oral

25.5

23.9

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

23.7

416

2377

F64.9

ICD-10 Finland

Gender identity disorder, unspecified

16.0

23.6

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

41.6

23.6

C03DA01

ATC

spironolactone; oral

2.0

23.4

322

1683

C10AA07

ATC

rosuvastatin; oral

1.6

23.4

753

5113

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

23.4

711

4759

205

Kela drug reimbursment

Chronic hypertension

1.5

23.3

811

5607

A04

ICPC

Weakness/tiredness general

1.7

23.2

487

2945

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

23.2

297

1509

A04AA01

ATC

ondansetron; systemic, rectal

2.0

23.0

300

1536

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

4.2

22.8

209

M04AA01

ATC

allopurinol; systemic

2.0

22.7

317

1667

D34

ICD-10 Finland

Benign neoplasm of thyroid gland

5.7

22.7

118

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.6

22.5

174

697

C09CA01

ATC

losartan; oral

1.5

22.4

809

5633

H53.2

ICD-10 Finland

Diplopia

2.9

22.3

139

489

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.8

22.2

S18

ICPC

Laceration/cut

1.4

22.1

1573

12528

B01AC04

ATC

clopidogrel; oral

1.9

22.1

343

1874

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.6

22.0

170

680

B01AB10

ATC

tinzaparin; parenteral

2.0

22.0

274

1379

GD1AD

NOMESCO Finland

Thorax CT examination

2.5

22.0

171

689

J01MA12

ATC

levofloxacin; systemic

1.6

21.7

639

4236

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

21.5

1854

15225

E04.8

ICD-10 Finland

Other specified nontoxic goitre

9.4

21.5

R13

ICD-10 Finland

Dysphagia

2.1

21.2

239

1153

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.5

21.1

164

658

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

21.1

953

6960

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

15.5

21.0

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

3.4

20.9

101

298

R42

ICD-10 Finland

Dizziness and giddiness

1.5

20.9

795

5598

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

20.9

955

6987

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

20.9

562

3640

E89.39

ICD-10 Finland

Postprocedural hypopituitarism, other or several procedures

+∞

20.8

102

Kela drug reimbursment

Diabetes insipidus

17.9

20.8

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

20.7

651

4382

LAF01

NOMESCO Finland

Laparoscopic unilateral salpingo-oophorectomy

2.7

20.7

140

519

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.1

20.6

245

1210

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

4.0

20.5

206

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.8

20.4

389

2278

XF404

NOMESCO Finland

Ambulatory ECG

1.9

20.3

307

1664

B01AA03

ATC

warfarin; systemic

1.6

20.2

522

3343

J01FF01

ATC

clindamycin; systemic

1.4

20.2

1047

7845

WX720

NOMESCO Finland

Own respiration

2.5

20.2

162

663

T89

ICPC

Diabetes insulin dependent

2.6

20.1

147

569

A28

ICPC

Limited function/disability NOS

1.7

20.1

432

2627

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

20.0

275

1437

E06.3

ICD-10 Finland

Autoimmune thyroiditis

5.6

20.0

104

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

20.0

258

1316

J01MA02

ATC

ciprofloxacin; systemic

1.4

19.9

1444

11488

G03DC03

ATC

lynestrenol; oral

2.7

19.8

138

520

24210

ICD-8 Finland

Thyrotoxicosis with or without goitre, Toxic nodular goitre

12.6

19.8

R51.80

ICD-10 Finland

Headache

1.6

19.7

605

4043

E24.0

ICD-10 Finland

Pituitary-dependent Cushing disease

73.8

19.7

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

6.1

19.6

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

3.0

19.6

118

406

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.1

19.5

231

1138

E87.5

ICD-10 Finland

Hyperkalaemia

13.8

19.5

JN5SN

NOMESCO Finland

40.2

19.5

R11

ICD-10 Finland

Nausea and vomiting

1.9

19.4

302

1650

A10AE05

ATC

insulin detemir; parenteral

2.3

19.4

184

822

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.6

19.3

529

3437

2420A

ICD-9 Finland

Thyrotoxicosis with or without goitre, Toxic diffuse goitre

15.6

19.2

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

12.2

19.0

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

19.0

1472

11815

A02BC03

ATC

lansoprazole; oral

1.4

19.0

1123

8611

N80.8

ICD-10 Finland

Other endometriosis

7.3

18.9

E66.8

ICD-10 Finland

Other obesity

2.1

18.9

226

1118

JAH00

NOMESCO Finland

Laparotomy

2.9

18.8

117

414

J02AC01

ATC

fluconazole; systemic

1.3

18.8

1944

16315

A09AA02

ATC

multienzymes (lipase, protease etc.)

3.6

18.7

234

XF402

NOMESCO Finland

ECG with work load test

1.8

18.7

335

1925

2504

FHL

Unilateral resection or enucleation

5.4

18.7

105

N06AX11

ATC

mirtazapine; oral

1.4

18.6

1250

9786

TFP20

NOMESCO Finland

Cardiodefibrillation

2.2

18.6

201

952

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

18.6

305

1700

R02

ICPC

Shortness of breath/dyspnoea

1.7

18.5

420

2593

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.2

18.5

197

926

130

Kela drug reimbursment

Malignant tumour

1.9

18.4

259

1367

J01DA01

ATC

[U] cefalexin; systemic

1.3

18.4

2653

23345

C09AA05

ATC

ramipril; oral

1.5

18.4

675

4701

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

18.4

1453

11685

128

Kela drug reimbursment

Cancers of female genital organs

3.1

18.4

101

329

TK800

NOMESCO Finland

Hemodialysis

4.1

18.3

179

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

2.1

18.0

218

1086

N97.8

ICD-10 Finland

Female infertility of other origin

3.1

18.0

101

334

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

2.6

18.0

132

516

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

17.9

398

2441

H50.2

ICD-10 Finland

Vertical strabismus

5.7

17.9

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

17.8

500

3268

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

5.7

17.8

301

Kela drug reimbursment

Growth hormone

66.8

17.7

PJD91

NOMESCO Finland

Excision of lymph nodes in neck, 1 to 2 areas in total

20.1

17.7

E29.1

ICD-10 Finland

Testicular hypofunction

7.3

17.7

BBA20

NOMESCO Finland

Exploration of parathyroid gland

8.5

17.6

JAH01

NOMESCO Finland

Laparoscopy

2.0

17.6

219

1102

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

4.0

17.6

176

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

17.5

193

922

R49.08

ICD-10 Finland

Other specified dysphonia

2.8

17.5

111

396

ZX108

NOMESCO Finland

Inhalation

7.2

17.5

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.8

17.5

J01AA02

ATC

doxycycline; systemic

1.3

17.5

3339

30501

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

42.1

17.3

H05.2

ICD-10 Finland

Exophthalmic conditions

9.8

17.1

M79.6

ICD-10 Finland

Pain in limb

1.3

17.0

1379

11104

BWD00

NOMESCO Finland

Reoperation for deep haemorrhage in endocrine surgery

25.7

16.9

BCA30

NOMESCO Finland

Unilateral adrenalectomy

21.9

16.8

A02BA02

ATC

ranitidine; systemic

1.5

16.8

709

5077

R06AE07

ATC

cetirizine; oral

1.3

16.8

1867

15742

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

16.8

388

2405

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

16.7

1157

9078

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

16.7

397

2480

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

16.6

468

3057

24209

ICD-8 Finland

Thyrotoxicosis with or without goitre, Cum struma diffuse NUD

15.1

16.6

Z01.7

ICD-10 Finland

Laboratory examination

1.6

16.6

411

2598

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

16.6

299

1721

L04AA06

ATC

mycophenolic acid; systemic

3.7

16.5

202

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

16.5

310

1808

C739

ICD-10 Finland

27.6

16.5

N18.8

ICD-10 Finland

Other chronic renal failure

3.6

16.4

203

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

16.4

400

2517

R03AC02

ATC

salbutamol; inhalant

1.3

16.4

2171

18743

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

16.3

282

1602

BBA50

NOMESCO Finland

Total parathyroidectomy

40.2

16.3

N99.4

ICD-10 Finland

Postprocedural pelvic peritoneal adhesions

4.1

16.3

155

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.6

16.3

478

3157

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

12.1

16.3

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.4

16.3

241

B03BA03

ATC

hydroxocobalamin; parenteral

2.1

16.2

186

904

SPAT1153

SPAT

Removal of sutures

1.4

16.2

1173

9263

CA1AD

NOMESCO Finland

Orbita CT

11.2

16.2

JAL21

NOMESCO Finland

Laparoscopic excision or destruction of lesion of peritoneum

3.3

16.2

242

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

16.1

360

2212

C08CA02

ATC

felodipine; oral

1.8

16.1

265

1483

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

16.0

454

2971

N06AX21

ATC

duloxetine; oral

1.6

16.0

441

2867

E21.2

ICD-10 Finland

Other hyperparathyroidism

8.2

16.0

A07AA02

ATC

nystatin; oral

1.9

15.8

243

1324

E06.2

ICD-10 Finland

Chronic thyroiditis with transient thyrotoxicosis

33.5

15.7

L02AE02

ATC

leuprorelin; implant, parenteral

2.5

15.7

122

494

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

15.7

892

6758

D39.11

ICD-10 Finland

Epithelial tumor of uncertain nature in the ovary

4.9

15.6

106

C08CA13

ATC

lercanidipine; oral

1.6

15.6

407

2607

E89.31

ICD-10 Finland

Postirradiation hypopituitarism

+∞

15.6

C02AC05

ATC

moxonidine; oral

2.4

15.6

129

538

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.2

15.6

266

C03AA03

ATC

hydrochlorothiazide; oral

1.8

15.5

298

1750

H02AB07

ATC

prednisone; oral

1.5

15.5

546

3760

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

4.3

15.5

134

JN4AD

NOMESCO Finland

Body CT examination

1.9

15.5

245

1350

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

4.5

15.4

121

J01FA09

ATC

clarithromycin; systemic

1.3

15.4

1313

10620

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

15.3

325

1966

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

15.3

533

3660

R4130

NOMESCO Finland

Speech therapy

3.1

15.3

281

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

15.2

358

2229

N06AX16

ATC

venlafaxine; oral

1.5

15.2

570

3977

Z31.5

ICD-10 Finland

Genetic counselling

1.9

15.1

234

1278

L04AA01

ATC

[U] ciclosporin; systemic

3.3

15.1

234

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

15.1

253

1424

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.0

15.1

206

1078

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

15.0

324

1970

XCK00

NOMESCO Finland

Perimetry

1.8

15.0

241

1335

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

15.0

1221

9797

J01FA10

ATC

azithromycin; systemic

1.3

15.0

2523

22364

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

4.4

15.0

125

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

5.2

14.9

A06AD11

ATC

lactulose; oral

1.6

14.8

427

2806

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

14.8

328

2012

A10BA02

ATC

metformin; oral

1.4

14.7

780

5828

KFC00

NOMESCO Finland

Unilateral orchiectomy

10.4

14.7

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

14.7

1538

12793

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.7

14.6

100

377

C07AA07

ATC

sotalol; systemic

2.5

14.6

111

445

CAC44

NOMESCO Finland

Combined decompression of orbit

80.3

14.6

R4190

NOMESCO Finland

Nutritional therapy

2.4

14.5

125

533

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

6.7

14.5

WW300

NOMESCO Finland

Transfer of autologic stem cells

7.3

14.4

BAA99

NOMESCO Finland

Other operation on thyroid gland

36.1

14.4

R49.01

ICD-10 Finland

Functional dysphonia

2.2

14.4

141

639

ZX121

NOMESCO Finland

Central venous catheter

7.8

14.3

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

14.3

352

2221

E24.9

ICD-10 Finland

Cushing syndrome, unspecified

27.2

14.3

R00.2

ICD-10 Finland

Palpitations

1.7

14.1

280

1660

R60.0

ICD-10 Finland

Localized oedema

1.6

14.1

354

2243

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

14.1

250

1433

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

14.1

210

1133

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.5

14.1

114

472

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

5.6

14.0

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.8

13.9

235

1323

IBZ08

NOMESCO Finland

Gender identity assessment

15.8

13.9

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

13.9

148

700

207

Kela drug reimbursment

Chronic arrhythmias

1.6

13.9

348

2204

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.1

13.8

160

785

T99

ICPC

Endocr/metab/nutrit disease other

3.4

13.8

201

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.9

13.8

198

1055

2419X

ICD-9 Finland

Non-toxic nodular goitre, Unspecified non-toxic nodular goitre

6.5

13.8

BAA20

NOMESCO Finland

Unilateral partial excision of thyroid gland

7.8

13.8

CAC30

NOMESCO Finland

Decompression of orbit to sinuses

53.5

13.8

N06AA09

ATC

amitriptyline; systemic

1.6

13.8

363

2330

G44.2

ICD-10 Finland

Tension-type headache

1.5

13.8

539

3794

C10AX09

ATC

ezetimibe; oral

1.8

13.7

260

1520

J01FA06

ATC

roxithromycin; oral

1.3

13.7

1643

13882

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

13.6

420

2802

J05AB11

ATC

valaciclovir; oral

1.5

13.6

516

3606

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.1

13.6

156

763

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

6.1

13.6

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

13.6

836

6402

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

13.5

2063

17959

E89.8

ICD-10 Finland

Other postprocedural endocrine and metabolic disorders

+∞

13.5

UKC02

NOMESCO Finland

Cystoscopy

1.5

13.5

431

2899

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

13.5

241

1383

WA039

NOMESCO Finland

Radiotherapy with free isotopes

140.4

13.4

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

4.2

13.4

120

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

13.3

535

3785

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.5

13.3

100

399

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

13.3

1537

12910

UDQ02

NOMESCO Finland

Direct laryngoscopy

4.7

13.2

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

13.1

182

957

L02AE03

ATC

goserelin; implant

3.3

13.1

194

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

2.1

13.0

151

739

TAB00

NOMESCO Finland

Lumbar puncture

2.0

13.0

177

922

L17

ICPC

Foot/toe symptom/complaint

1.3

13.0

908

7092

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

13.0

660

4886

XCK10

NOMESCO Finland

Photography of fundus of eye

1.6

13.0

312

1957

E22.0

ICD-10 Finland

Acromegaly and pituitary gigantism

16.7

13.0

A41.9

ICD-10 Finland

Sepsis, unspecified

2.4

12.9

106

441

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

12.9

477

3314

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

12.9

112

481

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.5

12.9

170

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

12.8

339

2178

XX3DW

NOMESCO Finland

Time consuming IT work

1.6

12.8

348

2250

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

12.8

179

945

RD210

NOMESCO Finland

2.9

12.7

259

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.5

12.7

167

A01AB09

ATC

miconazole; local oral

1.6

12.7

340

2194

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

4.8

12.6

9835/3-C42.1

ICD-O-3

Precursor cell lymphoblastic leukemia, NOS, of bone marrow

15.4

12.6

Z85.8

ICD-10 Finland

Personal history of malignant neoplasms of other organs and systems

15.4

12.6

AN1

Coronary angiography

1.7

12.6

238

1393

J01CA04

ATC

amoxicillin; systemic

1.3

12.6

3479

32446

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

12.5

105

445

2411A

ICD-9 Finland

Non-toxic nodular goitre, Non-toxic multinodular goitre

6.1

12.5

3025

Kela drug reimbursment

Calcium carbonate

17.3

12.5

8345/3-C73.9

ICD-O-3

Medullary thyroid carcinoma of thyroid gland

130.3

12.4

Y28

ICPC

Limited function/disability (Y)

13.2

12.4

N80.0

ICD-10 Finland

Endometriosis of uterus

2.3

12.4

117

524

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

12.3

296

1857

R03DC03

ATC

montelukast; oral

1.4

12.2

643

4784

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

4.4

12.2

E05.4

ICD-10 Finland

Thyrotoxicosis factitia

14.3

12.2

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

2.8

12.2

293

WW409

NOMESCO Finland

Other aferesis

9.0

12.2

D40.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Testis

9.0

12.2

M03BX02

ATC

tizanidine; oral

1.3

12.2

2616

23597

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.8

12.2

211

1202

PJD99

NOMESCO Finland

Excision of other lymph nodes

15.9

12.1

R03BA01

ATC

beclometasone; inhalant

1.4

12.1

538

3883

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

3.6

12.1

153

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

12.1

219

1266

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

12.0

399

2706

24220

ICD-8 Finland

Thyrotoxicosis with or without goitre, Thyrotoxicosis without mention of goitre

26.7

12.0

E24.8

ICD-10 Finland

Other Cushing syndrome

26.7

12.0

BCA31

NOMESCO Finland

Endoscopic unilateral adrenalectomy

8.2

12.0

C10AA03

ATC

pravastatin; oral

1.9

12.0

179

969

DQE10

NOMESCO Finland

Injection of foreign material into vocal cord

8.7

12.0

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

12.0

1020

8195

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

12.0

379

2544

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

11.9

314

2017

C95.0

ICD-10 Finland

Acute leukaemia of unspecified cell type

13.4

11.9

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

11.9

291

1832

D35.30

ICD-10 Finland

Craniopharyngoma

46.8

11.9

N06AB10

ATC

escitalopram; oral

1.4

11.9

788

6099

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

11.8

541

3924

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.2

11.8

118

542

E0000UV

ATC

1.3

11.8

1547

13149

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

11.8

251

1520

C01BD01

ATC

amiodarone; systemic

2.8

11.8

259

T81

ICPC

Goitre

6.1

11.8

C53.11

ICD-10 Finland

Squamous cell carcinoma and exocervix

8.4

11.8

A10AA02

ATC

2.2

11.7

111

500

C09DA01

ATC

losartan and diuretics; oral

1.6

11.7

307

1968

8442/1-C56.9

ICD-O-3

Serous borderline tumor, NOS, of ovary

6.6

11.7

R52.9

ICD-10 Finland

Pain, unspecified

1.6

11.7

284

1787

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

11.6

300

1917

SPAT1254

SPAT

Administration of medicine

1.5

11.6

462

3257

SPAT1263

SPAT

Sampling

1.3

11.6

1623

13899

BB1BQ

NOMESCO Finland

Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT

6.0

11.6

24200

ICD-8 Finland

Thyrotoxicosis with or without goitre, Cum struma diffusa et exophthalmo. Morbus Basedowi

12.5

11.6

GB1AA

NOMESCO Finland

Tracheal X-ray examination

12.5

11.6

C62.12

ICD-10 Finland

Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma

65.1

11.6

WW304

NOMESCO Finland

Transfer of stem cells from registered domestic donator

65.1

11.6

E89

ICD-10 Finland

Postprocedural endocrine and metabolic disorders, not elsewhere classified

65.1

11.6

E20

ICD-10 Finland

Hypoparathyroidism

65.1

11.6

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

2.8

11.6

264

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.0

11.6

149

764

E20.0

ICD-10 Finland

Idiopathic hypoparathyroidism

18.9

11.6

C62.11

ICD-10 Finland

Malignant tumor of the descending testicle, seminoma

22.9

11.6

6171A

ICD-9 Finland

Endometriosis of ovary

2.8

11.5

271

B01AF02

ATC

apixaban; oral

1.7

11.5

237

1424

R52.2

ICD-10 Finland

Other chronic pain

2.1

11.5

126

603

B01AB04

ATC

dalteparin; parenteral

1.9

11.5

169

909

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

11.5

919

7310

J02AC03

ATC

voriconazole; systemic

10.0

11.5

2513A

ICD-9 Finland

Other disorders of pancreatic internal secretion, Postsurgical hypoinsulinaemia

+∞

11.5

8510/3-C73.9

ICD-O-3

Medullary carcinoma, NOS, of thyroid gland

+∞

11.5

E06.9

ICD-10 Finland

Thyroiditis, unspecified

5.9

11.4

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

13.6

11.4

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

13.6

11.4

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

11.4

254

1560

JAL31

NOMESCO Finland

Laparoscopic omentectomy

6.7

11.4

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

7.5

11.4

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.9

11.4

226

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

11.4

162

863

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

11.3

809

6327

C10AC01

ATC

colestyramine; oral

2.3

11.3

102

449

WW402

NOMESCO Finland

Leucoferesis

11.8

11.3

107

Kela drug reimbursment

Pernicious anaemia

2.8

11.2

250

L91.0

ICD-10 Finland

Hypertrophic scar

3.1

11.2

196

UJD02

NOMESCO Finland

Gastroscopy

1.9

11.2

160

853

E23.03

ICD-10 Finland

Lack of ACTH

12.7

11.1

R01AD09

ATC

mometasone; nasal

1.2

11.1

1881

16447

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

4.2

11.1

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.2

11.0

113

527

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.9

11.0

161

867

HA1AA

NOMESCO Finland

X-ray mammography

1.6

11.0

325

2149

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.9

11.0

155

825

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

10.9

333

2215

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

43.4

10.9

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.9

10.9

156

832

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.4

10.9

398

WX882

NOMESCO Finland

High dependency care

2.5

10.9

324

N05BA01

ATC

diazepam; systemic, rectal

1.4

10.8

456

3253

TPH00

NOMESCO Finland

Phlebotomy

8.8

10.7

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

10.7

438

3106

N19

ICD-10 Finland

Unspecified kidney failure

2.7

10.7

278

E27.2

ICD-10 Finland

Addisonian crisis

28.1

10.7

H50.6

ICD-10 Finland

Mechanical strabismus

17.8

10.7

E23.09

ICD-10 Finland

Pituitary insufficiency NOS

17.8

10.7

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.1

10.6

115

550

CA1BM

NOMESCO Finland

Eye and orbita MRI examination with 3 Tesla magnet

60.1

10.6

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

10.6

152

813

ZX090

NOMESCO Finland

Other technic of radiotherapy

2.2

10.6

108

505

WX400

NOMESCO Finland

Inhalation anesthesy

1.8

10.6

173

968

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

6.3

10.6

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

8.5

10.5

R2110

NOMESCO Finland

Giving the first information

1.6

10.5

289

1876

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

9.2

10.5

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

10.5

390

2713

I50.0

ICD-10 Finland

Congestive heart failure

1.9

10.5

141

739

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.8

10.4

172

966

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

10.4

1519

13028

E89.3

ICD-10 Finland

Postprocedural hypopituitarism

+∞

10.4

BCA41

NOMESCO Finland

Endoscopic bilateral adrenalectomy

+∞

10.4

C62.10

ICD-10 Finland

Malignant tumor of the descending testicle, no histological verification

+∞

10.4

A10BH05

ATC

linagliptin; oral

2.1

10.4

109

516

F29

ICPC

Eye symptom/complaint other

1.6

10.4

291

1902

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.5

10.4

131

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

10.4

148

792

J01EA01

ATC

trimethoprim; systemic

1.3

10.3

1017

8311

2AX04

NOMESCO Finland

16.1

10.3

24400

ICD-8 Finland

Myxoedema, (hypothyreosis) post therapiam

16.1

10.3

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

10.3

532

3939

B81

ICPC

Anaemia vit B12/folate deficiency

2.1

10.3

115

558

A08

ICPC

Swelling

1.9

10.3

139

727

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

10.3

443

3176

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.9

10.3

102

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.2

10.2

437

C09CA06

ATC

candesartan; oral

1.3

10.2

737

5770

N80.89

ICD-10 Finland

Endometriosis with other specified or multiple localization

4.6

10.1

SPAT1325

SPAT

Vaccination

1.3

10.1

1190

9948

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.9

10.1

211

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

10.1

416

2958

SPAT1301

SPAT

No procedures

1.3

10.0

1124

9335

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

10.0

896

7226

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.9

10.0

137

722

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.6

10.0

230

1426

J46

ICD-10 Finland

Status asthmaticus

2.2

10.0

103

483

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

10.0

691

5368

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

10.0

1059

8735

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

10.0

1094

9063

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

10.0

322

2173

UDC00

NOMESCO Finland

Ear microscopy

1.6

9.9

244

1540

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1.9

9.9

140

743

KBV10

NOMESCO Finland

Removal of stent from ureter

4.2

9.9

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.7

9.9

201

1206

M05BX04

ATC

denosumab; parenteral

1.8

9.9

167

946

M54.5

ICD-10 Finland

Low back pain

1.3

9.9

1231

10352

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

9.9

366

2546

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.4

9.9

323

321

Kela drug reimbursment

Paricalcitol and cinacalcet

7.6

9.9

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

9.9

134

705

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

9.9

146

792

H01CB02

ATC

octreotide; parenteral

8.1

9.8

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

2.0

9.8

123

628

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.5

9.8

281

L02AB02

ATC

medroxyprogesterone; systemic (progestogens)

3.9

9.8

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.9

9.8

135

714

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.5

9.8

293

1942

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

10.6

9.8

M14.5*E03.9

ICD-10 Finland

Arthropathy in hypothyroidism (E00-E03+)

8.7

9.8

D07AA02

ATC

hydrocortisone; topical

1.4

9.8

491

3618

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.7

9.7

196

1172

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

9.7

430

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

9.7

243

1546

Z50.5

ICD-10 Finland

Speech therapy

3.0

9.6

187

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

9.6

446

3244

R21

ICPC

Throat symptom/complaint

1.3

9.5

779

6202

SPAT1097

SPAT

Recording of ECG

1.4

9.5

457

3341

H50.8

ICD-10 Finland

Other specified strabismus

9.1

9.5

RS221

NOMESCO Finland

2.9

9.5

196

2410A

ICD-9 Finland

Non-toxic nodular goitre, Non-toxic uninodular goitre

6.0

9.5

A01

ICPC

Pain general/multiple sites

1.6

9.5

258

1671

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

3.8

9.5

100

A10AA01

ATC

2.2

9.5

401

K80

ICPC

Cardiac arrhythmia NOS

1.6

9.4

239

1524

E85.9

ICD-10 Finland

Amyloidosis, unspecified

100.2

9.4

E05.3

ICD-10 Finland

Thyrotoxicosis from ectopic thyroid tissue

100.2

9.4

CAC20

NOMESCO Finland

Lateral decompression of orbit

30.1

9.4

24110

ICD-8 Finland

Non-toxic nodular goitre, Sporadic

7.5

9.4

E06.0

ICD-10 Finland

Acute thyroiditis

7.5

9.4

R10.0

ICD-10 Finland

Acute abdomen

2.1

9.4

108

531

XX1MN

NOMESCO Finland

Isotope examination with measurement

+∞

9.4

2572A

ICD-9 Finland

Testicular dysfunction, Other testicular hypofunction

+∞

9.4

R01AD08

ATC

fluticasone; nasal

1.3

9.4

1143

9580

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

9.3

464

3411

2273A

ICD-9 Finland

Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)

21.7

9.3

J02AC04

ATC

posaconazole; systemic

21.7

9.3

C01DA14

ATC

isosorbide mononitrate; oral

1.5

9.3

273

1801

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.5

9.3

289

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

9.3

1763

15512

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.0

9.3

116

589

M25.5

ICD-10 Finland

Pain in joint

1.3

9.3

1085

9047

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

9.2

962

7909

N06AB03

ATC

fluoxetine; oral

1.4

9.2

458

3368

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.6

9.2

258

1685

C08DB01

ATC

diltiazem; oral

1.9

9.2

130

694

SPAT1255

SPAT

Intravenous administration of medicine

1.7

9.1

205

1263

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

7.7

9.1

LCD30

NOMESCO Finland

Radical hysterectomy

8.3

9.0

J01MA14

ATC

moxifloxacin; systemic

1.5

9.0

295

1997

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

9.0

K02.1

ICD-10 Finland

Caries of dentine

1.2

9.0

2254

20364

LEB00

NOMESCO Finland

Biopsy of vagina

2.3

9.0

360

N05AH04

ATC

quetiapine; oral

1.3

8.9

564

4318

GD6AD

NOMESCO Finland

CT of chest and neck

6.5

8.9

D39.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Ovary

5.0

8.9

A10BH01

ATC

sitagliptin; oral

1.6

8.9

230

1471

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.9

8.9

181

C10AA04

ATC

fluvastatin; oral

1.7

8.9

196

1201

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

4.3

8.9

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.2

8.9

375

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

5.5

8.9

A27

ICPC

Fear of other disease NOS

1.8

8.9

145

815

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

8.9

1484

12871

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.1

8.8

443

HAC10

NOMESCO Finland

Subcutaneous mastectomy with preservation of mamilla

7.9

8.8

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.7

8.8

228

D01

ICPC

Abdominal pain/cramps general

1.4

8.8

368

2622

M01AX17

ATC

nimesulide; oral

1.3

8.8

875

7144

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

8.8

591

4570

N05CF02

ATC

zolpidem; oral

1.3

8.8

665

5233

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

8.7

591

4571

A98

ICPC

Health maint/preventive medicine

1.5

8.7

4355

42434

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

5.3

8.7

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

8.7

607

4717

R55

ICD-10 Finland

Syncope and collapse

1.5

8.7

291

1979

R03BA02

ATC

budesonide; inhalant

1.3

8.7

651

5114

5604

FHL

Vascular preparation or cannulation in the operating room

14.0

8.7

T86.9

ICD-10 Finland

Failure and rejection of unspecified transplanted organ and tissue

50.1

8.7

CBK00

NOMESCO Finland

Myotomy or resection of tarsal muscle or levator muscle of eyelid for correction of retraction

50.1

8.7

C09AA02

ATC

enalapril; systemic

1.4

8.7

519

3939

J05AB01

ATC

aciclovir; systemic

1.3

8.6

826

6707

A97

ICPC

No disease

1.4

8.6

475

3557

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.5

8.6

258

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

7.6

8.6

E23.2

ICD-10 Finland

Diabetes insipidus

7.6

8.6

E06.1

ICD-10 Finland

Subacute thyroiditis

3.5

8.6

109

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.8

8.6

689

8491

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

8.6

287

1952

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.4

8.6

308

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

8.5

257

1710

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

8.5

204

1281

E28.3

ICD-10 Finland

Primary ovarian failure

4.8

8.5

RL210

NOMESCO Finland

4.8

8.5

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

8.5

326

2285

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.5

8.5

300

2066

H03BB02

ATC

thiamazole; oral

20.0

8.5

-50

ICPC

Medication/prescr/renewal

1.8

8.5

138

776

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.4

8.5

303

R03BB04

ATC

tiotropium bromide; inhalant

1.5

8.4

257

1711

A03DA02

ATC

pitofenone and analgesics; systemic

2.3

8.4

324

I50.1

ICD-10 Finland

Left ventricular failure

2.1

8.4

410

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

8.4

660

5217

R03AC03

ATC

terbutaline; inhalant

1.3

8.4

518

3951

L02

ICPC

Back symptom/complaint

1.5

8.4

315

2196

C74.0

ICD-10 Finland

Malignant neoplasm: Cortex of adrenal gland

90.2

8.4

D07AC01

ATC

betamethasone; topical

1.2

8.4

1217

10377

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.0

8.4

103

521

LAC01

NOMESCO Finland

Laparoscopic excision of ovarian cyst

2.3

8.4

325

N05CD07

ATC

temazepam; oral

1.4

8.4

365

2621

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

8.4

1091

9194

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.7

8.4

201

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

8.4

171

1031

LAE10

NOMESCO Finland

Unilateral oophorectomy

4.2

8.4

9350/1-C75.2

ICD-O-3

Craniopharyngioma, NOS, of craniopharyngeal duct

+∞

8.3

E85.0

ICD-10 Finland

Non-neuropathic heredofamilial amyloidosis

+∞

8.3

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

8.3

210

1340

JAL01

NOMESCO Finland

Laparoscopic biopsy of peritoneum

5.0

8.3

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.9

8.3

117

625

YNB10

NOMESCO Finland

Collection of stem cells for transplant

8.5

8.3

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.0

8.3

151

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

8.3

1040

8725

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

8.3

441

3285

JEA00

NOMESCO Finland

Appendectomy

1.6

8.3

234

1532

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

3.2

8.3

129

H3600, E103

ICD-10 Finland

3.2

8.3

129

LAD00

NOMESCO Finland

Partial excision of ovary

5.5

8.3

G04CA02

ATC

tamsulosin; oral

1.4

8.3

327

2306

H01CB03

ATC

lanreotide; parenteral

7.1

8.2

8070/3-C53.9

ICD-O-3

Squamous cell carcinoma, NOS, of cervix uteri

7.1

8.2

K90.0

ICD-10 Finland

Coeliac disease

1.9

8.2

110

575

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

8.2

215

1383

L20

ICPC

Joint symptom/complaint NOS

1.9

8.2

122

662

K30

ICD-10 Finland

Functional dyspepsia

1.4

8.2

376

2728

J01DA06

ATC

[U] cefuroxime; systemic

1.3

8.2

536

4124

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

8.2

132

740

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

8.2

582

4534

A01AB04

ATC

amphotericin B; local oral

1.7

8.2

166

999

8204

FHL

Salpingo-oophorectomy

2.6

8.2

214

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.6

8.2

194

1218

UJC01

NOMESCO Finland

Scopy of lower throat

3.4

8.2

114

G03FA01

ATC

norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

1.3

8.2

533

4099

I47.2

ICD-10 Finland

Ventricular tachycardia

2.7

8.2

205

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.3

8.1

120

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

3.0

8.1

142

CD2S4

NOMESCO Finland

Photography of eye

5.4

8.1

E000001

ATC

1.3

8.1

745

6016

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.8

8.1

125

689

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.0

8.1

103

531

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.8

8.1

140

802

A29

ICPC

General symptom/complaint other

1.4

8.1

355

2556

A12BA01

ATC

potassium chloride; oral

1.9

8.1

109

574

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.2

8.1

352

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.4

8.0

269

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

8.0

267

1816

SPAT1336

SPAT

Request for examination

1.8

8.0

123

679

KFH50

NOMESCO Finland

Insertion of prosthetic replacement for testis

22.0

8.0

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

8.0

190

1191

H26.4

ICD-10 Finland

After-cataract

1.5

8.0

243

1622

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

8.0

645

5121

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

8.0

169

1030

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.8

8.0

166

G03HA01

ATC

cyproterone; systemic

4.6

8.0

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.4

8.0

326

2315

LAE11

NOMESCO Finland

Unilateral laparoscopic oophorectomy

3.6

7.9

KBV00

NOMESCO Finland

Insertion of stent into ureter

4.7

7.9

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

3.7

7.9

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.9

7.9

102

530

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.0

7.9

505

SPAT1260

SPAT

Consultation of another employee

1.3

7.9

592

4648

H02AB02

ATC

dexamethasone; systemic

1.4

7.9

358

2594

D46.9

ICD-10 Finland

Myelodysplastic syndrome, unspecified

6.6

7.9

E27.0

ICD-10 Finland

Other adrenocortical overactivity

13.0

7.9

8470/3-C56.9

ICD-O-3

Mucinous cystadenocarcinoma, NOS, of ovary

13.0

7.9

K05.1

ICD-10 Finland

Chronic gingivitis

1.5

7.9

259

1757

P06

ICPC

Sleep disturbance

1.4

7.8

330

2355

D27.91

ICD-10 Finland

Benign epithelial tumor of the ovary (ovary)

2.5

7.8

223

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

7.8

443

3332

E04

ICD-10 Finland

Other nontoxic goitre

5.4

7.8

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

7.8

401

2970

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

8.4

7.8

ZX020

NOMESCO Finland

HDR radiotherapy within tissue

8.4

7.8

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.1

7.8

400

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

7.8

252

1704

E000003

ATC

1.7

7.7

151

898

R07.3

ICD-10 Finland

Other chest pain

1.5

7.7

285

1984

M01AH02

ATC

rofecoxib; oral

1.4

7.7

444

3350

2521A

ICD-9 Finland

Disorders of parathyroid gland, Hypoparathyroidism

45.0

7.7

CEC90

NOMESCO Finland

Total transposition of extraocular muscle or muscles

45.0

7.7

B02AA02

ATC

tranexamic acid; systemic

1.3

7.7

640

5095

R09

ICPC

Sinus symptom/complaint

1.4

7.7

303

2135

N80

ICD-10 Finland

Endometriosis

3.4

7.7

104

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

7.4

7.7

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

7.4

7.7

R25.1

ICD-10 Finland

Tremor, unspecified

2.0

7.6

431

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.8

7.6

129

736

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

2.3

7.6

309

R4120

NOMESCO Finland

Occupational therapy

1.6

7.6

196

1258

TPX15

NOMESCO Finland

Removal of vascular injection port

4.4

7.6

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.6

7.6

188

1194

E66.9

ICD-10 Finland

Obesity, unspecified

1.9

7.6

113

616

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

7.6

502

3868

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

7.6

375

2756

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.2

7.6

322

N04BC06

ATC

cabergoline; oral (dopamine agonists)

4.2

7.6

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

4.9

7.6

A60

ICPC

General and Unspecified, Result test/procedure

1.7

7.5

144

851

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.8

7.5

H05BX01

ATC

cinacalcet; oral

5.7

7.5

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

2.0

7.5

455

C10AB05

ATC

fenofibrate; oral

2.9

7.5

148

L95

ICPC

Osteoporosis

1.9

7.5

108

582

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.7

7.5

133

772

Z94.0

ICD-10 Finland

Kidney transplant status

3.5

7.5

L60.0

ICD-10 Finland

Ingrowing nail

1.7

7.5

136

792

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

7.4

294

2075

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.4

7.4

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

4.4

7.4

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

7.4

1240

10712

5AD01

NOMESCO Finland

80.2

7.4

E83.59

ICD-10 Finland

Other disorders of calcium metabolism

80.2

7.4

LCW96

NOMESCO Finland

Other operation on uterus and uterine ligaments

80.2

7.4

C62.92

ICD-10 Finland

Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma

80.2

7.4

J45

ICD-10 Finland

Asthma

1.4

7.4

346

2519

A46

ICD-10 Finland

Erysipelas

1.4

7.4

366

2692

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.5

7.4

212

1398

CEC00

NOMESCO Finland

Recession of extraocular muscle

4.5

7.4

B02.9

ICD-10 Finland

Zoster without complication

1.6

7.4

176

1110

D06

ICPC

Abdominal pain localized other

1.5

7.4

276

1925

B03XA02

ATC

darbepoetin alfa; parenteral

2.8

7.4

158

C01AA05

ATC

digoxin; systemic

1.6

7.3

161

991

D11

ICPC

Diarrhoea

1.4

7.3

381

2823

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.4

7.3

250

5BA08

NOMESCO Finland

3.9

7.3

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

7.3

480

3695

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

7.3

302

M54.6

ICD-10 Finland

Pain in thoracic spine

1.5

7.3

238

1612

J37.0

ICD-10 Finland

Chronic laryngitis

1.9

7.3

105

567

I25.2

ICD-10 Finland

Old myocardial infarction

1.9

7.3

482

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.8

7.3

120

676

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.9

7.3

105

568

2754A

ICD-9 Finland

Disorders of mineral metabolism, Disorders of calcium metabolism[HYPERCALCAEMIA]

+∞

7.3

N08.4*E85.9

ICD-10 Finland

Glomerular disorders in amyloidosis

+∞

7.3

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

+∞

7.3

CA1BD

NOMESCO Finland

Extensive orbita CT

10.9

7.3

ZSB00

NOMESCO Finland

Procedure related to previous procedure classified in chapter B

10.9

7.3

J01CA08

ATC

pivmecillinam; oral

1.2

7.3

1825

16371

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

7.3

710

5771

T72

ICPC

Benign neoplasm thyroid

6.8

7.3

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.5

7.3

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.3

7.3

295

N05BA06

ATC

lorazepam; systemic, sublingual

1.7

7.3

150

909

B82

ICPC

Anaemia other/unspecified

2.2

7.2

328

R05

ICPC

Cough

1.3

7.2

788

6493

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.9

7.2

147

M01AG01

ATC

mefenamic acid; oral

1.8

7.2

110

605

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.3

7.2

265

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

7.2

387

2883

E06.5

ICD-10 Finland

Other chronic thyroiditis

15.7

7.2

D35.1

ICD-10 Finland

Benign neoplasm: Parathyroid gland

5.4

7.2

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

7.2

828

6869

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.4

7.2

299

2129

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.2

7.2

331

LAC00

NOMESCO Finland

Excision of ovarian cyst

4.6

7.2

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.9

7.2

104

565

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.0

7.2

415

WX723

NOMESCO Finland

CPAP therapy

1.9

7.1

102

551

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.3

7.1

279

C92.9

ICD-10 Finland

Myeloid leukaemia, unspecified

30.0

7.1

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

7.1

370

2745

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.9

7.1

133

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.5

7.1

246

1690

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.3

7.1

291

N06AB04

ATC

citalopram; systemic

1.3

7.1

769

6329

M01AE02

ATC

naproxen; oral, rectal

1.2

7.1

2277

20856

WX610

NOMESCO Finland

Patient controlled analgesia

3.4

7.1

2AB04

NOMESCO Finland

5.0

7.1

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

7.1

228

1542

R03BA08

ATC

ciclesonide; inhalant

1.4

7.1

291

2071

I95.1

ICD-10 Finland

Orthostatic hypotension

2.1

7.1

348

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.5

7.1

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.0

7.1

446

D70.89

ICD-10 Finland

Neutropenic splenomegaly

2.7

7.0

174

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.0

7.0

424

SPAT1281

SPAT

Other administrative function

1.5

7.0

252

1743

M05BA04

ATC

alendronic acid; oral

1.5

7.0

269

1887

R05FB02

ATC

cough suppressants and expectorants

1.2

7.0

1389

12189

JFB46

NOMESCO Finland

Resection of sigmoid colon

2.7

7.0

158

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

7.0

416

3158

A02BX02

ATC

sucralfate; oral

1.7

7.0

125

728

N97.1

ICD-10 Finland

Female infertility of tubal origin

2.7

7.0

168

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.8

7.0

104

569

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

6.9

162

1017

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

6.3

6.9

L03

ICPC

Low back symptom/complaint

1.2

6.9

852

7118

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

2.8

6.9

147

C56.92

ICD-10 Finland

Malignant ovarian tumor, sex chord stroma derived

7.5

6.9

EP1AT

NOMESCO Finland

Punction of soft tissue of neck with ultrasound guidance

13.8

6.9

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.9

6.9

505

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

6.9

401

3031

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.3

6.8

252

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.8

6.8

109

612

L12

ICPC

Hand/finger symptom/complaint

1.3

6.8

487

3797

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

6.8

255

1778

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.9

6.8

538

J38.3

ICD-10 Finland

Other diseases of vocal cords

2.8

6.8

142

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

6.8

1879

16970

J21.0

ICD-10 Finland

Acute bronchiolitis due to respiratory syncytial virus

6.7

6.8

XKD00

NOMESCO Finland

Uroflowmetry

1.4

6.8

284

2025

T73

ICPC

Neoplasm endocrine other/unspecified

10.9

6.8

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

3.2

6.8

104

A03FA02

ATC

cisapride; oral, rectal

1.5

6.8

239

1650

A99

ICPC

Disease/condition unspecnature/site

1.5

6.8

236

1624

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

9.3

6.8

JAL97

NOMESCO Finland

Other laparoscopic excision of lesion of peritoneum

6.1

6.8

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

6.1

6.8

8290/3-C73.9

ICD-O-3

Oxyphilic adenocarcinoma of thyroid gland

40.1

6.8

H50.0

ICD-10 Finland

Convergent concomitant strabismus

3.2

6.8

E23

ICD-10 Finland

Hypofunction and other disorders of pituitary gland

16.7

6.7

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.4

6.7

275

1952

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

6.7

526

4151

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.7

6.7

126

744

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

6.7

655

5325

M01AE51

ATC

ibuprofen, combinations; systemic

2.3

6.7

249

S22

ICPC

Nail symptom/complaint

1.6

6.7

178

1153

OAB72

NOMESCO Finland

Weight control and weight loss guidance

3.5

6.7

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.7

6.7

151

J01DC02

ATC

cefuroxime; systemic

1.5

6.7

201

1343

N01

ICPC

Headache

1.4

6.6

343

2545

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.1

6.6

351

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.5

6.6

204

JFB00

NOMESCO Finland

Partial resection of small intestine

2.6

6.6

176

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.7

6.6

120

703

9061/3-C62.9

ICD-O-3

Seminoma, NOS, of testis, NOS

12.2

6.6

2429X

ICD-9 Finland

Thyrotoxicosis with or without goitre, Thyrotoxicosis without mention of goitre or other cause

12.2

6.6

9863/3-C42.1

ICD-O-3

Chronic myeloid leukemia, NOS, of bone marrow

12.2

6.6

N70.1

ICD-10 Finland

Chronic salpingitis and oophoritis

2.3

6.6

233

A10AE06

ATC

insulin degludec; parenteral

1.9

6.6

431

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.4

6.6

270

1923

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.3

6.6

253

CEW99

NOMESCO Finland

Other operation on extraocular muscle

8.7

6.5

I70.1

ICD-10 Finland

Atherosclerosis of renal artery

8.7

6.5

1CX01

NOMESCO Finland

8.7

6.5

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

6.5

136

825

UJK02

NOMESCO Finland

ERCP

2.1

6.5

333

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

4.8

6.5

C90.0

ICD-10 Finland

Multiple myeloma

3.2

6.5

102

K92.1

ICD-10 Finland

Melaena

1.8

6.5

110

631

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.2

6.5

810

6773

R31

ICD-10 Finland

Unspecified haematuria

1.5

6.5

206

1393

Z93.2

ICD-10 Finland

Ileostomy status

5.3

6.4

R96

ICPC

Asthma

1.4

6.4

285

2057

ZX070

NOMESCO Finland

Intensity modified radiotherapy

2.2

6.4

260

C56.72

ICD-10 Finland

Mucinous epithelial carcinoma of the ovary

5.7

6.4

XF602

NOMESCO Finland

Bloodpressure monitoring

3.1

6.4

103

M02AA07

ATC

piroxicam; topical

1.2

6.4

1311

11516

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

2.9

6.4

120

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

6.4

207

1404

WF003

NOMESCO Finland

Adjuvant radiotherapy

1.7

6.4

114

660

N17

ICPC

Vertigo/dizziness

1.4

6.4

337

2508

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.0

6.4

404

355

Kela drug reimbursment

Dienogest

7.4

6.4

C74.9

ICD-10 Finland

Malignant neoplasm: Adrenal gland, unspecified

14.3

6.4

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

14.3

6.4

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.9

6.4

433

C07AG02

ATC

carvedilol; oral

1.6

6.4

138

849

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.7

6.4

121

718

N02AC04

ATC

dextropropoxyphene; oral

1.8

6.4

551

ZXB10

NOMESCO Finland

Medial

3.6

6.4

ED1AA

NOMESCO Finland

Mandipular X-ray examination

3.6

6.4

R01AD12

ATC

fluticasone furoate; nasal

1.2

6.4

1166

10138

H53.4

ICD-10 Finland

Visual field defects

2.2

6.4

275

R03AC12

ATC

salmeterol; inhalant

1.6

6.3

136

834

N83.0

ICD-10 Finland

Follicular cyst of ovary

2.2

6.3

284

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.7

6.3

153

6173A

ICD-9 Finland

Endometriosis of pelvic peritoneum[ENDOMETRIOSIS SEROSAE PELVIS]

2.7

6.3

153

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.7

6.3

122

725

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

6.3

2073

18951

KAC10

NOMESCO Finland

Total nephrectomy with capsule

3.4

6.3

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

2.3

6.3

225

S97

ICPC

Chronic ulcer skin

1.7

6.3

127

766

C53.01

ICD-10 Finland

Squamous cell carcinoma of the endocervix

5.9

6.3

G03GA01

ATC

chorionic gonadotrophin; parenteral

1.6

6.3

158

1010

H03AA02

ATC

liothyronine sodium; systemic

9.2

6.3

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.0

6.3

387

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

4.0

6.3

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

18.0

6.3

WX872

NOMESCO Finland

Intensive care

1.8

6.3

102

578

25219

ICD-8 Finland

Diseases of parathyroid gland, Hypoparathyreoidismus alius sive NUD

+∞

6.2

E8901, E050

ICD-10 Finland

+∞

6.2

E87.2

ICD-10 Finland

Acidosis

+∞

6.2

E83.58

ICD-10 Finland

Idiopathic hypercalciuria

+∞

6.2

2768A

ICD-9 Finland

Disorders of fluid, electrolyte and acid-base balance, Hypopotassaemia[HYPOKALAEMIA]

+∞

6.2

EB1WA

NOMESCO Finland

3.3

6.2

M01AH05

ATC

etoricoxib; oral

1.2

6.2

2348

21691

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.0

6.2

403

C74.1

ICD-10 Finland

Malignant neoplasm: Medulla of adrenal gland

26.7

6.2

2542

FHL

Transasal hypophysectomy

26.7

6.2

E13.7

ICD-10 Finland

Other specified diabetes mellitus, with multiple complications

26.7

6.2

M01AG02

ATC

tolfenamic acid; oral, rectal

1.3

6.2

637

5207

AA4CM

NOMESCO Finland

Extensive MRI examination of sella turcica with 3 Tesla magnet

7.0

6.2

J01FA15

ATC

telithromycin; oral

1.4

6.2

357

2694

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

6.2

1532

13680

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.8

6.2

105

603

A10BK03

ATC

empagliflozin; oral

1.6

6.2

165

1073

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.6

6.2

165

-34

ICPC

Blood test

1.8

6.2

557

Y84.9

ICD-10 Finland

Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.8

6.2

WF002

NOMESCO Finland

Radical radiotherapy

1.7

6.2

112

657

R07.0

ICD-10 Finland

Pain in throat

1.5

6.1

205

1403

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.4

6.1

322

2397

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.9

6.1

399

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.8

6.1

104

596

-31

ICPC

Medical examin/health eval partial

1.5

6.1

213

1468

R05

ICD-10 Finland

Cough

1.3

6.1

645

5296

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

6.1

316

2349

C07AB03

ATC

atenolol; systemic

1.6

6.1

148

942

M48.0

ICD-10 Finland

Spinal stenosis

1.4

6.1

321

2390

T28

ICPC

Limited function/disability (T)

2.9

6.0

123

3AC01

NOMESCO Finland

2.9

6.0

123

212

Kela drug reimbursment

Gout

2.7

6.0

143

FM2CE

NOMESCO Finland

8.6

6.0

R03AK08

ATC

formoterol and beclometasone; inhalant

1.7

6.0

123

745

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

4.9

6.0

ZX112

NOMESCO Finland

Subcutaneous

2.0

6.0

352

6170A

ICD-9 Finland

Endometriosis of uterus

2.5

6.0

171

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

6.0

126

767

WX780

NOMESCO Finland

Remote monitoring CPAP

1.7

6.0

105

606

A04AA02

ATC

granisetron; systemic, transdermal

1.5

6.0

193

1308

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3607

19239

3.82

307.65

12.2

5.2

1.2

mmol/l

53.13

3067

16137

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

796

198

47.24

307.65

7.4

5.8

—

(3018418) pH of Serum or Plasma

2626

11277

3.67

307.65

8.4

3.3

7.4

0.24

534

2158

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

836

371

26.63

307.65

7.4

3.7

48.9

99.6

u/ml

1.05

306

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3290

17324

3.42

307.65

10.5

4.7

1.2

mmol/l

54.78

3121

15576

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1032

1093

11.52

307.65

3.0

1.8

11.5

4.0

iu/l

0.81

608

391

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1244

2583

6.01

307.65

4.3

3.1

55.5

79.4

ng/l

19.89

1095

2217

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2104

2834

11.75

307.65

6.7

3.0

4.5

pmol/l

0.70

1969

2530

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1212

3999

3.64

303.46

7.4

4.5

1.1

1.0

mmol/l

10.17

1128

3691

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4829

35331

5.79

302.29

12.1

4.1

16.3

14.6

pmol/l

318.85

4670

32464

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1423

5444

3.22

278.50

5.1

3.0

0.8

mmol/l

14.55

1337

5068

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3021

18225

2.56

234.20

3.1

2.2

76.6

77.9

nmol/l

1.68

2841

16539

(3015377) Calcium [Moles/volume] in Serum or Plasma

2454

13857

2.45

213.45

4.1

3.2

2.3

2.4

mmol/l

40.15

2242

12161

(3024561) Albumin [Mass/volume] in Serum or Plasma

2663

16586

2.23

172.41

6.4

4.1

36.0

36.1

g/l

0.39

2499

15356

(3036481) Cortisol [Moles/volume] in Serum or Plasma

910

3603

2.85

158.98

2.8

2.1

368.0

372.4

nmol/l

0.15

854

3321

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4909

40967

4.24

155.61

13.7

4.7

2.0

mu/l

0.00

4732

37914

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4192

32242

2.51

153.63

10.6

6.8

75.9

u/l

0.02

4045

30265

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

430

1083

4.24

153.54

1.4

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

153

140

11.23

144.30

1.9

1.5

16.4

15.0

pmol/l

1.08

137

119

(3013650) Neutrophils [#/volume] in Blood by Automated count

3385

24307

2.11

139.05

12.2

8.7

3.9

e9/l

0.23

3024

21290

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

321

703

4.80

136.60

2.9

2.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

3197

22778

2.04

130.13

6.5

3.8

6.6

6.5

mmol/l

1.33

3040

20980

(3044640) Blood type and Crossmatch panel - Blood

2085

12938

2.02

123.78

3.1

2.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

813

3587

2.50

111.48

1.3

1.2

184.5

157.0

iu/ml

0.88

359

1417

(3010838) Calcium [Moles/time] in 24 hour Urine

141

178

8.11

104.41

2.0

1.7

6.1

6.3

mmol/24h

0.04

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2897

20897

1.87

102.74

8.3

5.6

9.9

10.4

umol/l

2.77

2769

19740

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2769

19723

1.86

101.92

4.9

3.7

—

(3001604) Monocytes [#/volume] in Blood

2884

20848

1.85

100.79

7.3

5.7

0.6

e9/l

0.28

2551

18116

(3013115) Eosinophils [#/volume] in Blood

2967

21665

1.85

100.09

7.7

5.9

0.2

e9/l

0.04

2648

19178

(3006315) Basophils [#/volume] in Blood

2884

20928

1.84

98.70

7.3

5.7

0.0

e9/l

0.49

2550

18158

(3032080) INR in Blood by Coagulation assay

2142

14194

1.86

98.21

10.0

6.9

1.2

inr

0.68

701

4249

(3019198) Lymphocytes [#/volume] in Blood

2944

21519

1.84

98.20

7.3

5.7

1.9

e9/l

0.61

2648

19104

(42870588) Differential panel, method unspecified - Blood

2064

13525

1.87

98.01

7.5

5.9

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

716

3169

2.46

96.63

6.7

3.0

1.2

mmol/l

26.64

651

2724

(3022096) Basophils/100 leukocytes in Blood

2641

18801

1.82

94.76

7.6

5.9

0.7

0.96

2501

17472

(3021589) Normoblasts [#/volume] in Blood

2610

18649

1.80

91.23

12.7

8.4

0.0

e9/l

0.29

2153

15233

(3006504) Eosinophils/100 leukocytes in Blood

2694

19445

1.80

90.85

7.5

5.8

2.8

0.17

2543

18047

(3019069) Monocytes/100 leukocytes in Blood

2705

19556

1.79

90.64

7.8

6.1

8.5

8.3

1.50

2567

18281

(3002030) Lymphocytes/100 leukocytes in Blood

2768

20175

1.79

89.96

7.6

5.9

28.3

29.1

3.18

2625

18755

(3033658) Prothrombin time (PT) actual/Normal

1596

9867

1.89

89.07

5.0

3.3

94.5

94.7

0.10

1562

9607

(3044889) 12 lead EKG panel

3643

29004

1.84

86.09

4.2

3.2

—

(3002032) Base excess in Venous blood by calculation

604

2614

2.48

85.02

4.8

3.2

2.1

2.0

mmol/l

0.40

498

2125

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2683

19591

1.76

84.64

3.6

2.7

118.6

98.9

ug/l

3.85

2500

18290

(3012544) pH of Venous blood

621

2732

2.44

84.32

4.8

3.2

7.4

—

(3011985) Renin [Units/volume] in Plasma

190

404

4.84

83.45

2.7

1.3

51.5

49.9

mu/l

0.06

171

361

(3026782) Osmolality of Urine

1222

7048

1.96

83.24

3.2

2.4

527.2

534.3

mosm/kgh2o

0.53

1064

5939

(3018010) Neutrophils/100 leukocytes in Blood

2709

19925

1.75

82.47

7.4

5.6

56.8

56.6

0.51

2569

18595

(3013707) Erythrocyte sedimentation rate by Westergren method

3927

32222

1.88

81.57

4.7

3.9

12.4

11.3

mm/h

5.19

3712

29941

(3021447) Carbon dioxide [Partial pressure] in Venous blood

599

2637

2.44

81.06

4.8

3.2

5.9

5.8

kpa

1.47

580

2555

(3019550) Sodium [Moles/volume] in Serum or Plasma

4933

44220

3.04

80.52

21.8

11.9

139.7

139.8

mmol/l

1.19

4851

43036

(3014576) Chloride [Moles/volume] in Serum or Plasma

791

3933

2.19

80.37

9.0

6.1

104.4

104.6

mmol/l

0.72

775

3860

(3002385) Erythrocyte distribution width [Ratio]

4314

36578

2.03

80.35

24.6

13.7

13.6

2.99

4244

35746

(3020779) Urea [Moles/volume] in Serum or Plasma

566

2445

2.47

79.77

11.7

6.0

8.8

8.5

mmol/l

0.53

543

2337

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1231

7215

1.92

79.44

3.5

2.8

2.4

mmol/l

12.55

1085

6338

(3023103) Potassium [Moles/volume] in Serum or Plasma

4940

44383

3.05

78.97

22.4

12.0

3.9

mmol/l

10.68

4850

43087

(3022948) Iron [Moles/volume] in Serum or Plasma

1010

5541

2.02

78.94

2.9

2.1

13.1

13.7

umol/l

1.65

939

5128

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

876

4566

2.10

78.69

3.0

2.2

22.5

23.1

0.54

744

3914

(40758558) Short blood count panel - Blood

1633

10538

1.80

77.14

9.8

6.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

931

5000

2.05

77.01

2.9

2.1

2.4

g/l

0.68

872

4621

(3018095) Leukocytes [#/volume] in Urine

1999

13720

1.74

75.97

4.5

3.2

78.7

99.6

e6/l

0.87

1437

9334

(3002582) Erythrocytes [#/volume] in Urine

1702

11251

1.76

73.23

3.8

2.7

28.7

83.7

e6/l

3.37

1335

8467

(3003396) Base excess in Arterial blood by calculation

708

3497

2.19

72.66

7.5

6.6

1.0

1.1

mmol/l

0.24

573

2709

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1500

9586

1.79

72.33

2.4

2.1

2.9

mg/l

0.19

1300

8233

(3027801) Oxygen [Partial pressure] in Arterial blood

706

3509

2.17

71.23

7.5

6.6

13.0

12.9

kpa

0.18

677

3346

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

706

3510

2.17

71.18

7.5

6.6

5.1

kpa

0.81

677

3350

(3030467) Casts [#/volume] in Urine by Automated count

1592

10403

1.76

70.83

3.7

2.7

0.3

0.4

e6/l

1.91

1224

7741

(3023368) Bacteria identified in Blood by Culture

1419

9021

1.79

69.10

6.0

3.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

717

3631

2.13

68.80

2.0

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

718

3652

2.12

68.07

2.0

1.6

—

(3016502) Oxygen saturation in Arterial blood

632

3062

2.21

67.80

8.0

7.0

96.0

0.04

609

2952

(3002173) Hemoglobin [Mass/volume] in Arterial blood

601

2883

2.23

65.98

8.2

7.2

119.9

121.1

g/l

0.72

576

2775

(3000991) Gas panel - Venous blood

535

2445

2.32

65.94

9.2

7.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

180

447

4.13

64.91

2.6

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1494

9804

1.73

64.29

2.8

2.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

137

280

5.00

63.02

3.5

2.0

19.7

19.5

nmol/l

0.08

128

267

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

696

3616

2.07

62.00

8.4

4.2

233.4

239.9

u/l

0.58

662

3434

(3017446) Testosterone [Moles/volume] in Serum or Plasma

386

1564

2.59

61.79

3.8

2.0

11.6

12.0

nmol/l

0.32

352

1393

(36304419) Bacteria [Presence] in Urine

1538

10278

1.70

61.40

3.7

2.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1911

13522

1.65

61.25

3.6

3.0

30.5

31.7

u/l

0.42

1829

12829

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

385

1566

2.57

61.13

8.8

9.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

948

5505

1.88

61.04

2.1

1.7

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1624

11057

1.68

60.20

2.3

1.9

174.5

186.1

u/l

0.24

1539

10378

(3018677) aPTT in Platelet poor plasma by Coagulation assay

885

5051

1.91

60.02

3.2

2.0

29.9

29.4

1.38

865

4889

(3000850) Epithelial cells [#/volume] in Urine

1243

7921

1.75

58.48

2.9

2.3

5.8

6.9

e6/l

2.10

1096

6863

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1388

9137

1.71

57.98

3.5

2.6

1233.5

998.2

ng/l

1.00

1201

7662

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2152

15836

1.61

57.95

2.1

1.8

96.5

98.6

pmol/l

1.23

1158

7937

(3027945) Reticulocytes/100 erythrocytes in Blood

668

3521

2.03

56.90

4.6

2.5

1.8

1.7

0.93

603

3147

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

520

2496

2.20

56.63

1.9

1.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4800

43619

2.22

55.57

20.1

11.3

20.4

21.2

mg/l

1.01

4034

33620

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1769

12538

1.62

54.81

2.9

2.3

56.8

58.0

u/l

0.33

1645

11547

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1072

6710

1.75

53.04

4.1

3.0

214.0

385.5

ng/l

1.40

767

4582

(3004119) Hemoglobin [Mass/volume] in Venous blood

398

1764

2.36

52.28

4.3

2.6

129.2

129.8

g/l

0.21

383

1720

(3007164) IgA [Mass/volume] in Serum or Plasma

1313

8745

1.67

51.47

1.6

1.4

2.2

2.3

g/l

0.76

825

5389

(3026008) Bacteria identified in Urine by Culture

1737

12404

1.60

51.38

3.3

2.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

776

4458

1.87

50.88

6.5

2.5

6.2

7.1

umol/l

0.94

685

3802

(3037467) Urinalysis macro (dipstick) panel - Urine

3487

29214

1.58

50.41

5.1

4.0

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

528

2678

2.08

49.63

7.8

6.0

1.2

1.3

mmol/l

0.61

513

2594

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1490

10342

1.62

49.16

1.4

1.3

1.6

1.4

u/ml

0.34

432

2923

(3012565) Volume of 24 hour Urine

155

5.82

48.83

2.5

2.2

1918.6

1924.6

0.02

142

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

925

5670

1.77

48.79

3.5

2.5

3.3

3.6

e6/l

0.37

470

2942

(3031040) Bacteria [#/volume] in Urine by Automated count

3353

27977

1.55

48.11

5.2

4.1

528.1

2220.1

e6/l

3.11

312

(3010375) cycloSPORINE [Mass/volume] in Blood

138

6.10

47.75

39.7

23.5

139.0

118.3

ug/l

1.79

116

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

991

6258

1.72

46.84

3.2

2.4

1.0

1.3

e6/l

1.19

528

3509

(3027273) Bicarbonate [Moles/volume] in Venous blood

321

1364

2.44

46.23

4.1

2.6

26.1

25.5

mmol/l

2.17

308

1323

(3035350) Ketones [Presence] in Urine by Test strip

2602

20716

1.51

45.22

4.2

3.4

0.0

estimate

1.08

546

3821

(3005719) IgG [Mass/volume] in Serum or Plasma

559

2997

1.97

44.83

3.2

2.8

10.0

10.6

g/l

3.19

515

2764

(3009508) Creatinine [Moles/volume] in Urine

1547

11038

1.57

44.53

3.3

3.0

6.8

7.3

mmol/l

4.72

1347

9287

(3042936) Bacteria identified in Isolate by Culture

849

5202

1.75

44.46

2.2

1.9

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

141

387

3.72

44.22

1.4

1.3

322.1

288.4

pmol/l

0.47

121

297

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

11.98

43.66

3.8

1.8

56.5

41.3

pmol/l

0.82

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

157

467

3.43

43.62

1.8

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

2603

20872

1.49

42.73

5.7

4.6

0.0

estimate

0.80

558

3882

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1860

13925

1.52

42.58

3.8

2.9

201.7

80.1

ng/l

0.32

1149

8179

(3020682) Albumin/Creatinine [Ratio] in Urine

1470

10460

1.56

42.42

4.2

3.7

12.6

6.9

mg/mmol

2.44

913

6165

(3012516) Albumin [Mass/volume] in Urine

1413

9977

1.57

42.13

3.5

3.0

747.4

396.1

mg/l

1.22

870

5817

(3009261) Glucose [Presence] in Urine by Test strip

2620

21074

1.49

42.10

4.2

3.5

0.0

estimate

0.34

545

3838

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

165

518

3.26

42.07

1.8

1.2

0.4

nmol/l

0.04

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1333

9309

1.58

41.61

2.4

1.7

1.2

1.0

mg/l

0.45

1030

7032

(4035726)

645

3714

1.84

41.42

1.5

1.4

—

(40768804) Tissue Pathology biopsy report

2365

18706

1.48

40.90

2.3

2.0

—

(3023520) Reticulocytes [#/volume] in Blood

487

2572

1.99

40.63

3.6

2.5

71.8

69.4

e9/l

0.69

360

1906

(3026493) Urate [Moles/volume] in Serum or Plasma

1389

9876

1.55

39.74

3.2

2.2

4205.2

3815.5

umol/l

0.14

1231

8583

(3021960) Folate [Moles/volume] in Serum or Plasma

1233

8534

1.58

39.70

1.6

1.5

21.0

21.1

nmol/l

0.06

1096

7297

(3036603) Volume of Urine

207

4.61

39.61

1.6

1.4

1908.8

1888.1

0.04

(3024354) Oxygen [Partial pressure] in Venous blood

434

2224

2.04

39.37

3.9

2.7

4.5

4.6

kpa

0.31

419

2153

(40761511) CBC panel - Blood by Automated count

4921

46006

2.18

39.28

18.4

10.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

191

679

2.88

39.28

10.3

4.5

673.9

342.2

iu/ml

0.69

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

304

1355

2.32

39.24

5.3

3.6

24.5

24.3

mmol/l

0.30

277

1206

(40760892) CBC W Ordered Manual Differential panel - Blood

1380

9837

1.55

38.88

5.1

4.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

390

1934

2.10

38.64

7.3

6.6

24.8

24.7

mmol/l

0.34

362

1790

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

647

3809

1.80

38.47

3.9

2.8

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

282

1232

2.36

38.10

5.0

4.9

1.7

1.6

0.47

266

1152

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

195

4.63

37.74

2.4

2.7

37.0

43.2

0.77

(3020630) Protein [Mass/volume] in Serum or Plasma

493

2697

1.91

36.97

3.3

2.4

66.3

66.9

g/l

1.13

462

2465

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

139

426

3.32

36.87

4.3

3.1

4.0

17.1

nmol/l

0.51

134

417

(3007930) Methemoglobin/Hemoglobin.total in Blood

279

1233

2.33

36.71

5.0

4.9

0.9

0.16

263

1150

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4493

41013

1.68

36.16

18.4

10.2

83.6

84.2

ml/min/173m2

1.02

3948

33610

(3019060) Gas panel - Arterial blood

393

2004

2.04

36.07

5.1

4.7

—

(3047181) Lactate [Moles/volume] in Blood

236

980

2.47

35.67

5.1

5.7

1.2

mmol/l

0.19

206

852

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

326

1560

2.16

35.38

9.6

8.4

24.5

24.3

mmol/l

0.43

306

1453

(3004588) Protein electrophoresis panel - Serum or Plasma

419

2201

1.98

35.36

3.2

2.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

978

6600

1.59

34.45

1.8

1.7

1204.9

1180.2

nmol/l

0.35

781

5039

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

282

1290

2.25

34.20

2.1

1.8

1.5

g/l

0.09

250

1103

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

580

3418

1.78

34.16

2.3

2.1

0.2

g/l

1.39

551

3223

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4299

38974

1.58

33.78

6.2

4.8

39.7

38.5

mmol/mol

15.08

4066

36165

(3028026) IgM [Mass/volume] in Serum or Plasma

424

2283

1.93

33.24

1.9

1.2

1.4

g/l

0.79

396

2101

(3007853) Bacteria identified in Skin by Aerobe culture

725

4598

1.67

32.67

1.9

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

215

899

2.45

32.01

1.4

1.2

—

(3039000) Anion gap in Blood

176

672

2.68

31.63

5.9

6.9

11.3

11.0

mmol/l

0.51

160

597

(3018572) Chloride [Moles/volume] in Blood

176

673

2.67

31.54

5.9

6.9

105.6

mmol/l

0.03

160

598

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4937

46656

2.04

31.14

14.6

9.2

25.3

25.0

u/l

0.77

4840

45020

(21494815) CD4 cells/100 lymphocytes in Specimen

107

310

3.50

31.03

2.6

2.2

35.2

44.1

0.98

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1456

10927

1.46

30.57

1.8

1.6

1.4

1.3

mmol/l

3.11

1257

9184

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

258

3.73

30.34

2.8

665.4

758.2

e6/l

0.44

114

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

8.22

30.34

1.2

2.1

6.8

pmol/l

—

(3002256) Pathology report gross observation

854

5739

1.58

30.24

1.3

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

144

509

2.88

29.97

3.9

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

109

327

3.38

29.96

1.3

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

169

4.43

29.86

1.8

1.5

4.3

6.1

nmol/l

0.24

128

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

448

2545

1.83

29.65

3.8

2.6

182.0

154.2

ng/l

0.56

406

2300

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

205

871

2.41

29.48

4.8

3.1

1.4

1.5

ratio

0.24

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

210

903

2.38

29.40

4.8

3.2

29.8

43.1

mg/l

1.10

169

733

(3034860) Kappa light chains.free [Mass/volume] in Serum

210

905

2.38

29.26

4.8

3.2

44.3

53.9

mg/l

0.51

168

731

(3037522) Nuclear Ab [Titer] in Serum

911

6267

1.55

28.99

1.4

495.7

581.1

titre

0.72

178

1363

(1616796) Gas panel - Central venous blood

169

663

2.60

28.79

3.8

3.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

186

767

2.48

28.55

1.5

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

248

1161

2.19

28.41

2.0

1.3

14.5

12.9

u/l

0.74

201

965

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

591

3684

1.68

28.21

2.7

2.2

45.3

51.8

u/l

0.18

523

3137

(3003181) Sodium [Moles/volume] in Urine

111

353

3.19

27.79

1.5

1.3

60.8

68.3

mmol/l

1.09

273

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

194

827

2.40

27.70

4.0

3.3

1.4

mg/l

0.49

182

764

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

126

434

2.95

27.51

1.9

1.5

—

(3010421) pH of Blood

198

861

2.35

27.04

4.0

3.0

7.4

0.14

170

709

(3008295) Osmolality of Serum or Plasma

275

3.46

26.90

1.7

1.6

281.3

284.4

mosm/kgh2o

0.69

207

(40760888) Immunoglobulin light chains.free panel - Serum

166

669

2.53

26.77

4.5

3.3

—

(3012501) Base excess in Blood by calculation

174

718

2.47

26.69

4.1

3.2

2.7

2.6

mmol/l

0.30

129

477

(3024932) HLA-DR beta [Type]

5.40

26.61

1.3

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4519

41959

1.57

26.46

4.8

4.0

5.9

5.7

mmol/l

8.44

4244

38540

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

172

713

2.46

26.13

1.6

1.3

111.5

114.6

u/ml

0.13

165

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

191

831

2.35

26.06

2.2

1.5

—

(3024471) HLA-A [Type]

5.30

26.02

1.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

171

711

2.45

25.81

1.8

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

150

586

2.61

25.80

2.2

1.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

318

1702

1.92

25.28

1.9

2.0

38.4

40.4

u/l

0.99

285

1557

(3008536) Aspergillus sp Ab [Presence] in Serum

6.31

25.23

4.7

1.9

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

331

1797

1.90

25.21

1.1

1.3

2.2

u/ml

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

108

359

3.05

25.12

2.0

1.5

—

(3037756) Immunofixation for Serum or Plasma

153

612

2.55

25.08

2.5

1.6

—

(3016244) Insulin [Units/volume] in Serum or Plasma

264

3.41

24.95

2.8

3.5

17.9

26.4

mu/l

1.88

252

(3052851) Hemolysis interference index of Serum or Plasma

228

1092

2.14

24.66

3.9

2.8

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

608

3944

1.61

24.63

3.7

4.0

84.9

20.2

ug/l

0.59

472

3077

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

186

820

2.32

24.63

2.3

1.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

260

1314

2.03

24.37

1.6

1.8

0.2

g/l

1.62

242

1247

(37021550) Renin [Units/volume] in Plasma --upright

6.16

24.06

1.6

1.3

88.7

45.3

mu/l

0.68

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

237

1166

2.08

23.90

2.7

2.1

94.4

94.3

0.04

221

1076

(3021387) Prolactin [Units/volume] in Serum or Plasma

311

1684

1.90

23.86

2.3

1.6

320.5

297.6

mu/l

0.56

286

1510

(3009445) Proteinase 3 Ab [Units/volume] in Serum

288

1529

1.94

23.45

1.7

1.5

11.9

14.4

u/ml

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

227

1110

2.09

23.27

1.5

1.4

288.4

294.5

ug/g

0.16

134

622

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

158

670

2.40

22.87

2.1

1.6

44.6

43.0

nmol/l

0.26

153

653

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

219

1064

2.10

22.84

3.7

2.5

3.5

3.6

g/l

0.79

212

1005

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

171

753

2.31

22.73

1.3

1.2

305.6

268.2

u/ml

0.86

115

474

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

192

891

2.20

22.51

4.6

3.0

0.3

0.4

u/ml

1.22

111

494

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

258

1340

1.97

22.40

3.7

2.3

0.6

0.7

0.54

247

1274

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

178

804

2.26

22.29

1.3

1.2

—

(3036489) Thrombin time

265

1394

1.95

22.17

2.4

1.9

21.4

21.0

0.57

234

1181

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

260

1359

1.96

22.16

1.6

1.8

1.2

g/l

1.27

241

1293

(3015235) Bicarbonate [Moles/volume] in Capillary blood

162

705

2.34

22.13

3.3

2.6

25.2

25.1

mmol/l

0.19

144

613

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

150

631

2.42

22.11

1.3

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

223

3.44

21.71

1.6

1.3

4.3

4.8

umol/l

0.42

206

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

489

3104

1.63

21.53

3.4

3.3

37.1

50.7

u/ml

0.87

473

2998

(3011397) Hemoglobin [Presence] in Urine by Test strip

1251

9649

1.39

21.13

3.9

3.5

—

(40768797) Stomach Pathology biopsy report

813

5801

1.48

21.11

1.3

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1448

11442

1.37

21.05

3.9

3.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

215

1075

2.04

20.78

3.1

2.4

188.7

179.3

0.77

206

1024

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

116

446

2.64

20.67

2.3

1.7

178.5

198.4

pmol/l

0.86

107

417

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1115

8468

1.40

20.56

1.7

1.6

39957928.5

35071003.0

pmol/l

0.11

941

7157

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1956

16236

1.33

20.30

4.4

3.5

—

(40767503) Oxygen content in Capillary blood by calculation

152

671

2.30

20.12

2.9

2.1

16.4

16.5

0.05

327

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

183

872

2.14

20.10

3.2

2.1

0.0

g/l

0.00

175

815

(3016650) Hepatitis A virus Ab [Presence] in Serum

150

661

2.31

19.94

1.3

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

164

3.75

19.87

1.6

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

164

3.75

19.87

1.6

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

184

883

2.12

19.84

3.2

2.1

0.0

g/l

0.50

175

817

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

105

393

2.71

19.74

9.0

6.2

11.4

11.1

mg/l

0.28

361

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

235

1237

1.94

19.64

3.1

3.5

313.9

1417.0

u/ml

0.70

208

1045

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

223

1153

1.98

19.63

3.5

2.2

9.8

10.4

g/l

1.09

195

980

(40760409) HLA-A [Type] by High resolution

11.81

19.57

1.0

—

(40760410) HLA-B [Type] by High resolution

11.81

19.57

1.0

—

(46236302) HLA-C [Type] by High resolution typing

11.81

19.57

1.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

216

1108

1.99

19.45

1.9

2.0

10.5

10.9

mg/l

0.24

204

1033

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3277

29307

1.32

19.44

3.4

2.8

46.4

40.4

u/l

2.83

3094

27504

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.77

19.28

1.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

235

1245

1.93

19.27

3.4

2.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

235

1246

1.93

19.22

3.4

2.1

7.4

7.3

g/l

0.18

190

953

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

107

412

2.63

19.04

1.3

—

(3035941) MCH [Entitic mass]

5077

49168

2.12

18.99

30.3

16.9

30.1

30.2

3.75

5032

48502

(3024731) MCV [Entitic volume]

5077

49170

2.12

18.95

30.3

16.9

90.6

90.8

2.19

5032

48505

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

234

1245

1.92

18.95

3.4

2.1

3.9

3.7

g/l

0.42

185

901

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

225

1182

1.94

18.92

3.3

2.2

3.0

3.1

g/l

0.39

187

927

(3010813) Leukocytes [#/volume] in Blood

5078

49186

2.12

18.90

30.5

17.0

6.6

e9/l

1.06

4982

47858

(3026361) Erythrocytes [#/volume] in Blood

5077

49178

2.11

18.81

30.4

16.9

4.5

e12/l

0.23

4984

47868

(3028626) Oxygen [Partial pressure] in Capillary blood

142

627

2.30

18.81

3.2

2.9

8.4

kpa

0.05

135

580

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

191

949

2.05

18.80

3.2

2.1

0.0

g/l

0.22

182

880

(3007461) Platelets [#/volume] in Blood

5073

49135

2.09

18.64

30.5

17.0

261.1

260.1

e9/l

0.50

4990

47939

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

12.90

18.55

1.7

3.4

—

(3021901) Oxygen saturation in Capillary blood

121

502

2.44

18.44

3.1

2.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

5076

49191

2.09

18.36

30.6

17.0

133.5

134.5

g/l

5.40

5031

48522

(3011412) CD3 cells [#/volume] in Blood

102

391

2.64

18.32

3.0

2.4

1.3

1.2

e9/l

0.33

240

(3048929) Epstein Barr virus Ab [Presence] in Serum

240

1302

1.88

18.32

1.3

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

229

1228

1.90

18.12

1.8

1.6

560.0

310.8

titre

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

110

441

2.53

18.04

2.6

—

(3024928) Oxygen saturation in Venous blood

134

588

2.31

18.02

4.0

2.5

—

(40761536) Microorganisms panel - Urine sediment

538

3637

1.53

17.98

4.7

3.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

179

884

2.06

17.93

1.5

1.3

54.6

24.7

e6/l

0.44

131

697

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

194

987

2.00

17.90

3.2

2.0

37.9

38.1

g/l

0.16

179

857

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

179

885

2.06

17.87

1.5

1.4

300.6

1433.8

e6/l

2.00

141

735

(3009542) Hematocrit [Volume Fraction] of Blood

4335

40602

1.40

17.66

22.6

12.2

39.3

39.7

2.72

3214

30662

(3029937) Albumin [Presence] in Urine by Test strip

1390

11169

1.33

17.47

4.7

3.8

0.0

estimate

2.12

543

3840

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

205

1073

1.95

17.44

3.5

2.2

0.8

0.9

g/l

0.24

188

939

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

171

841

2.07

17.33

3.4

3.8

57.0

56.7

0.09

171

841

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

289

2.87

17.31

2.3

2.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

138

625

2.24

17.24

1.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

362

2251

1.65

17.23

1.1

53.5

212.0

titre

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

279

2.90

17.21

3.0

2.6

593.3

510.0

e6/l

0.85

236

(3025159) Blasts/100 leukocytes in Blood

463

3072

1.56

16.81

4.3

4.2

0.0

0.4

1.17

123

686

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

176

885

2.02

16.80

1.7

1.4

0.3

0.4

nmol/l

1.20

138

682

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

316

1910

1.70

16.75

3.8

3.1

5.2

kpa

0.03

297

1773

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

304

1820

1.71

16.69

3.7

3.0

2.1

1.8

mmol/l

0.84

225

1362

(3007566) Smooth muscle Ab [Titer] in Serum

206

1102

1.90

16.44

1.2

1.3

74.2

162.9

titre

0.87

(40763590) HLA-DQ beta [Type]

10.62

16.43

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

458

3047

1.55

16.42

2.5

1.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

313

1899

1.69

16.36

1.8

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

271

2.87

16.32

3.2

2.7

0.2

e9/l

0.20

234

(44806118)

100

403

2.51

16.26

2.1

1.4

—

(44790049)

100

403

2.51

16.26

2.1

1.4

—

(44790047)

100

403

2.51

16.26

2.1

1.4

—

(44790048)

100

403

2.51

16.26

2.1

1.4

—

(3009343) pH of Capillary blood

310

1880

1.69

16.23

3.8

3.1

7.4

0.13

257

(36660697) Celiac disease serology panel - Serum

531

3670

1.50

15.92

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

314

2.70

15.91

2.4

2.0

12.7

14.4

0.49

152

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

141

666

2.15

15.91

1.2

1.1

—

(3013862) HLA-DP [Type]

10.03

15.80

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

5.19

15.77

2.0

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

448

2999

1.54

15.61

1.8

1.3

30.8

30.2

iu/l

0.12

368

2621

(3000060) B lymphocytes [#/volume] in Blood

122

3.80

15.35

2.1

2.2

226.4

145.4

e6/l

0.57

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

118

3.84

15.25

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

1467

12065

1.30

15.19

1.6

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

587

4180

1.46

15.10

22.7

20.3

1.2

inr

0.43

645

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1024

8018

1.34

15.01

1.3

9.1

11.7

u/ml

0.66

399

3304

(3017181) Myelocytes/100 leukocytes in Blood

489

3366

1.50

14.93

4.5

4.1

1.0

0.8

0.54

138

856

(3017817) Protein [Mass] in Urine collected for unspecified duration

246

2.87

14.91

2.9

2.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

4.11

14.87

1.5

0.4

ug/l

0.03

(3024980) IgG subclass 4 [Mass/volume] in Serum

139

671

2.10

14.85

1.9

1.6

0.7

g/l

0.04

100

507

(3022145) Colonoscopy Study observation

644

4690

1.43

14.66

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

147

730

2.04

14.57

2.5

2.1

128.3

130.2

g/l

0.39

112

518

(3021440) Promyelocytes/100 leukocytes in Blood

470

3228

1.50

14.50

4.4

4.2

0.1

0.2

0.42

130

793

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

129

614

2.13

14.31

1.5

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

679

5018

1.41

14.20

1.7

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

129

3.59

14.18

1.2

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

424

2.36

14.16

1.8

1.3

3.0

2.9

g/l

0.08

294

(3024139) IgG subclass 3 [Mass/volume] in Serum

424

2.36

14.16

1.8

1.3

0.3

0.4

g/l

1.20

290

(3000494) Fungus identified in Specimen by Culture

652

4788

1.41

14.14

1.6

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

168

888

1.92

13.95

1.4

1.2

3.7

mmol/l

0.15

157

833

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

187

1025

1.85

13.89

2.6

2.2

216.5

610.4

ug/l

1.15

172

939

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1060

8430

1.32

13.83

1.3

26.1

32.7

iu/ml

0.67

341

2710

(3002179) Metamyelocytes/100 leukocytes in Blood

451

3105

1.50

13.74

4.3

4.0

0.8

0.5

1.19

109

638

(3027135) IgG subclass 1 [Mass/volume] in Serum

425

2.33

13.64

1.8

1.3

6.5

6.7

g/l

0.19

294

(3045142) Bone marrow Pathology biopsy report

370

2.43

13.61

1.9

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

242

2.79

13.60

1.2

—

(3003338) MCHC [Mass/volume]

4047

37906

1.30

13.51

26.5

14.5

331.5

331.8

g/l

0.96

4019

37619

(4062490)

417

2.33

13.32

1.9

1.4

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

21.18

13.31

1.6

2.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

430

2.30

13.29

1.2

69.5

55.1

u/l

0.96

285

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

127

619

2.08

13.27

1.2

1.1

—

(3025941) Bacteria identified in Stool by Culture

372

2477

1.54

13.26

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

136

681

2.02

13.21

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

136

681

2.02

13.21

1.4

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

195

1103

1.80

13.10

1.2

1.3

448.0

840.2

titre

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

389

2624

1.52

13.06

2.3

2.1

7.3

6.2

ug/l

0.36

334

2290

(21494434) Karyotype in Bone marrow

271

2.64

12.98

1.3

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

117

559

2.12

12.89

2.3

2.6

31.7

34.6

umol/l

0.73

487

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4589

43836

1.38

12.88

5.2

4.3

2.8

2.9

mmol/l

9.13

4326

40541

(3048689) Calprotectin [Mass/mass] in Stool

748

5705

1.36

12.84

2.2

2.3

110.1

116.8

ug/g

0.28

607

4457

(3015171) Extractable nuclear Ab [Units/volume] in Serum

301

1925

1.60

12.80

1.3

0.4

1.3

u/ml

1.81

176

(3014148) Varicella zoster virus Ab [Titer] in Serum

120

581

2.09

12.78

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

157

838

1.90

12.69

1.6

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

115

3.59

12.67

33.1

33.4

7.2

7.3

ug/l

0.23

104

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

133

673

2.00

12.57

1.5

1.4

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

20.06

12.44

1.7

2.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

466

3309

1.45

12.11

1.6

1.4

—

(3023410) Appearance of Cerebral spinal fluid

399

2.28

11.95

1.7

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

128

651

1.99

11.94

2.0

0.8

nmol/l

0.30

109

557

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

301

1958

1.57

11.92

1.6

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

179

1019

1.78

11.80

1.5

1.3

472.4

492.7

mg/l

0.31

168

972

(3004451) EKG impression Narrative

116

3.47

11.78

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

299

2.46

11.59

1.2

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

6.35

11.54

3.7

2.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

113

3.47

11.51

4.7

2.9

101.2

146.1

ng/l

0.30

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

100

473

2.14

11.36

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

421

2.21

11.35

1.5

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

192

1137

1.71

11.05

2.5

2.0

2.5

2.0

ug/l

0.23

172

1015

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

116

588

1.99

10.96

1.5

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

133

710

1.90

10.81

2.0

1.4

1.9

3.8

ug/l

3.69

620

(3017704) Immunofixation for Urine

146

3.03

10.47

2.7

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

413

2947

1.44

10.44

1.5

1.3

164.4

189.1

u/ml

0.39

388

2748

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3284

30361

1.22

10.44

3.4

3.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.86

10.37

1.3

1.2

628.0

275.6

pmol/l

1.09

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

243

2.53

10.31

1.7

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.14

10.30

1.5

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

443

3216

1.41

10.18

2.9

2.4

63.2

70.4

ml/min/173m2

3.47

190

1191

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

108

3.35

10.11

2.0

2.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4325

41244

1.28

10.10

4.2

3.5

1.3

1.2

mmol/l

17.28

4055

38035

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

172

1015

1.72

10.06

2.2

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

326

2.29

10.04

1.3

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

176

1050

1.70

9.90

2.5

2.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4501

43168

1.31

9.89

4.7

3.9

4.7

4.9

mmol/l

13.87

4248

40198

(3051651) Icteric interference index of Serum or Plasma

214

2.59

9.77

6.9

2.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

100

502

2.01

9.75

1.7

1.5

24.2

22.2

iu/ml

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

230

1475

1.59

9.73

2.0

1.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

391

2.14

9.59

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

283

2.35

9.55

2.9

1.9

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

118

3.15

9.44

2.0

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

106

551

1.94

9.38

4.0

3.1

0.8

nmol/l

0.85

417

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

489

2.00

9.37

1.3

1.2

91.1

35.8

u/l

1.01

429

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

443

2.05

9.28

1.7

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

245

2.42

9.18

1.0

1.1

4.1

13.0

nmol/l

0.61

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

5.31

9.15

2.4

2.8

1.3

1.1

mg/l

0.12

(3020891) Body temperature

207

1315

1.60

9.13

6.3

4.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

175

2.70

9.13

1.6

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

101

524

1.95

9.00

1.6

1.4

—

(4281824)

108

574

1.90

8.97

1.2

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1102

9247

1.24

8.89

1.6

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

237

2.42

8.85

1.5

5.5

5.6

u/l

0.05

201

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

139

2.89

8.83

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

371

2.12

8.83

5.9

2.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4465

42901

1.28

8.78

4.6

3.9

1.5

mmol/l

17.88

4200

39796

(3013512) EKG study

1300

11145

1.22

8.50

3.9

3.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

203

1307

1.58

8.48

1.1

4.8

6.3

u/ml

0.27

177

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

274

2.28

8.42

1.3

1.4

1.3

1.4

nmol/l

0.28

243

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

173

1077

1.63

8.32

1.2

1.3

34.3

40.9

u/ml

0.25

122

(40768446) Kidney Pathology biopsy report

102

3.15

8.21

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

409

2.02

8.21

2.4

1.6

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

234

2.36

8.15

1.8

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

387

5171

0.73

8.13

4.7

4.0

32.4

32.7

0.26

283

3539

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

298

2.20

8.10

1.3

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

164

2.64

8.01

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

449

1.95

7.93

1.3

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

5.17

7.92

14.6

6.4

5.2

6.1

mmol/l

0.53

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

171

2.59

7.90

1.7

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

278

2.21

7.73

1.2

1.1

—

(40768795) Lymph node Pathology biopsy report

419

1.97

7.70

1.4

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.51

7.64

4.3

5.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

4.73

7.63

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

18.37

7.59

1.2

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

175

2.53

7.56

1.7

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

193

2.45

7.55

1.6

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

187

2.47

7.55

1.4

1.3

127.7

132.5

nmol/l

0.37

187

(42529406) Shigella sp [Presence] in Stool by Culture

190

1241

1.55

7.50

1.2

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

315

2.11

7.47

1.2

70.0

212.5

titre

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

369

2.02

7.45

2.5

1.7

—

(3011648) Oxygen content in Venous blood

219

2.34

7.44

2.0

2.1

10.6

11.3

0.49

219

(3000492) Spirometry study

529

4144

1.31

7.43

1.5

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

238

2.28

7.42

1.3

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.90

7.42

1.2

1.1

—

(3019150) Specific gravity of Urine by Refractometry

1054

8960

1.22

7.36

4.5

3.9

1.0

kg/l

0.30

162

1288

(3014765) Yersinia sp identified in Stool by Organism specific culture

188

1237

1.54

7.20

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

268

2.18

7.14

1.7

1.5

6.2

5.7

u/l

0.10

129

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.50

6.98

1.7

1.3

76.4

100.1

ng/l

0.40

(4212803)

4.58

6.92

1.2

1.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

155

985

1.59

6.92

5.4

3.9

3.8

mmol/l

0.52

144

936

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.56

6.85

1.3

2.0

—

(3037121) Protein [Mass/volume] in Urine

182

1205

1.53

6.79

3.0

2.9

0.2

0.3

g/l

0.48

444

(3030313) Adrenal Ab [Titer] in Serum

4.26

6.74

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

185

1233

1.52

6.70

1.2

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

110

2.83

6.67

4.0

1.6

2.8

2.0

ug/l

0.46

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

351

1.98

6.62

1.3

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

219

1520

1.46

6.51

1.7

1.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

115

689

1.68

6.51

2.8

2.4

63.6

72.8

ug/min

0.16

391

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

846

7117

1.23

6.48

1.7

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

140

884

1.60

6.45

1.6

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

254

2.14

6.40

2.4

1.9

—

1.9

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

105

617

1.72

6.38

1.2

1.3

63.2

52.9

u/ml

—

(1761482) Bacteria [#/volume] in Urine by Culture

133

833

1.61

6.34

4.3

4.2

—

(3009992) Blasts/100 cells in Bone marrow

18.03

6.26

2.2

2.0

8.4

6.4

—

(3042733) HLA Ab [Presence] in Serum

3.06

6.18

4.0

5.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

194

2.28

6.11

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

566

1.73

6.07

1.2

1.1

69.7

15929.8

iu/ml

0.56

152

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

391

1.88

6.05

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

283

2085

1.38

6.04

2.8

2.1

4710.1

4623.4

u/l

0.01

100

818

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

576

1.71

5.98

1.9

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

194

1343

1.46

5.88

1.3

—

(3013727) Leukocytes other/100 leukocytes in Blood

2.82

5.82

6.2

3.6

52.4

52.5

0.01

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

320

1.95

5.76

1.5

1.3

1.8

1.0

u/ml

0.25

141

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

411

3223

1.30

5.75

2.4

19.3

24.4

au/ml

0.53

218

(3044941) Cell count panel - Synovial fluid

584

1.69

5.71

1.7

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

380

2961

1.31

5.58

1.3

51.7

47.4

au/ml

0.10

137

(3024891) Influenza virus A+B Ag [Presence] in Specimen

163

1102

1.49

5.58

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

197

1389

1.43

5.45

1.2

1.3

29.5

40.5

u/ml

0.30

103

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

2.96

5.40

4.5

4.1

36.8

95.5

u/l

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

103

633

1.64

5.36

1.3

1.2

3.6

3.9

u/ml

0.06

213

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.13

5.35

1.5

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

317

1.90

5.24

2.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

317

1.90

5.24

2.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

317

1.90

5.24

2.5

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

972

8451

1.18

5.17

1.9

1.8

—

(3020393) Adenovirus Ag [Presence] in Stool

4.01

5.16

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

183

2.19

5.14

1.4

1.6

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

348

1.85

5.13

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

348

1.85

5.13

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

349

1.84

5.08

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

350

1.84

5.04

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

350

1.84

5.04

1.1

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

205

2.11

5.00

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

351

1.83

5.00

1.1

1.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.70

5.00

1.0

1.2

99.5

97.2

0.19

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.70

5.00

1.0

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

344

1.84

4.99

3.5

4.0

7.0

6.9

mmol/l

0.13

281

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

142

2.33

4.90

1.2

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

214

2.07

4.87

1.6

2.2

103.7

102.2

0.08

197

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

255

1.97

4.86

1.7

1.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

255

1.97

4.86

1.2

1.0

0.9

1.1

u/l

2.66

109

(3044927) Protein electrophoresis panel - Urine

297

1.90

4.86

1.2

1.1

—

(3022313) Gas panel - Capillary blood

191

1369

1.41

4.86

4.1

3.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

215

2.06

4.81

1.7

1.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

9.01

4.78

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

306

1.87

4.78

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

209

2.07

4.77

1.7

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

176

2.17

4.77

1.2

0.3

g/l

0.70

147

(40768443) Skin Pathology biopsy report

253

1905

1.34

4.76

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

607

1.61

4.74

1.2

1.1

120.3

118.5

0.19

551

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.95

4.70

1.1

118.9

0.7

umol/24h

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

303

1.86

4.59

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

240

1.97

4.58

1.4

1.5

26.6

19.8

u/ml

—

(4010399)

371

2963

1.27

4.54

1.5

1.4

—

(3049717) Cytology report of Urine Cyto stain

151

1051

1.45

4.54

2.6

2.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

200

1466

1.38

4.49

1.7

1.9

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

123

2.37

4.47

2.4

1.8

—

(3017569) Oxygen content in Arterial blood

143

2.25

4.39

1.7

2.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

132

901

1.48

4.39

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

613

1.58

4.35

1.3

1.2

5.7

3.8

u/ml

0.56

261

(4027681)

273

1.88

4.34

1.3

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

211

2.00

4.30

1.1

63.4

18.7

u/l

0.47

166

(3004809) Band form neutrophils/100 leukocytes in Blood

568

1.59

4.29

4.8

3.3

1.5

1.4

0.08

453

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

212

1.99

4.25

1.1

119.9

77.2

u/l

0.58

173

(3033705) Calcium.ionized [Moles/volume] in Venous blood

326

1.79

4.24

2.5

2.2

—

(3023419) Bacteria identified in Sputum by Culture

424

1.68

4.21

3.1

2.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.14

4.20

6.8

5.9

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.14

4.20

2.9

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

579

1.58

4.20

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

255

1.89

4.19

1.1

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

248

1.90

4.19

1.4

1.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.08

4.16

1.4

1.2

—

(3047189) Immunofixation for 24 hour Urine

134

2.25

4.14

3.4

1.5

—

(3021788) Differential panel - Synovial fluid

106

702

1.52

4.11

1.7

1.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

257

1.88

4.10

1.1

1.0

—

(4306422)

623

1.55

4.08

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.63

4.05

1.7

2.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

175

2.06

4.04

1.9

1.5

1.1

1.3

nmol/l

0.72

137

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

361

1.73

4.04

1.2

1.3

—

titre

—

(1002224) Polysomnography panel

238

1824

1.32

4.02

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

281

1.82

4.00

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

163

2.09

3.96

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.82

3.95

1.0

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

2.82

3.95

1.6

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

3.13

3.92

1.1

1.2

—

(4094501)

142

1008

1.42

3.89

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

171

1254

1.38

3.88

1.2

1.3

1.5

5.0

u/ml

0.93

138

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

306

1.77

3.88

2.6

2.7

—

(21494755) Public health laboratory ask at order entry panel

415

4991

0.82

3.80

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

266

2088

1.29

3.79

2.4

2.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

101

675

1.51

3.78

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

172

1269

1.37

3.77

1.3

30.1

6.5

u/ml

0.73

231

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

302

1.76

3.75

1.7

1.6

—

(3000012) Reticulocyte production index

167

2.04

3.74

1.3

1.6

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

6.67

3.67

1.9

2.7

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.86

3.62

6.7

5.8

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

104

2.31

3.58

1.1

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

228

1.85

3.49

1.2

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

376

3104

1.23

3.49

1.3

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

158

2.03

3.49

2.8

1.9

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.42

3.46

1.1

—

(3016750) Collection duration of Urine

173

1.97

3.42

2.4

2.3

496.8

495.7

min

0.03

130

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

612

5317

1.17

3.26

4.8

4.5

2.0

2.6

ug/l

1.49

544

4751

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

179

1362

1.33

3.25

1.6

0.1

5.0

iu/ml

0.53

260

(3032868) Hemoglobin electrophoresis panel in Blood

3.03

3.24

1.5

—

(3045716) Anion gap in Serum or Plasma

149

2.02

3.24

2.7

1.8

9.1

9.5

mmol/l

0.31

116

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

102

707

1.45

3.24

1.1

3.7

3.6

u/ml

0.02

350

(3000330) Specific gravity of Urine by Test strip

233

1839

1.28

3.23

3.4

3.1

—

(3042631) Mycobacterium sp identified in Specimen

433

1.58

3.21

2.1

2.8

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.34

3.19

1.3

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.31

3.16

1.2

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.41

3.13

1.2

—

(3025315) Body weight

4.51

3.11

6.2

3.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

139

2.02

3.05

6.1

3.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

635

1.46

3.01

1.1

—

(3025130) Human papilloma virus identified in Specimen

115

827

1.40

3.01

1.7

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

433

1.55

3.00

1.2

1.1

95.8

95.6

0.02

413

(3035880) pH of Pleural fluid

140

2.01

2.99

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

379

1.59

2.96

1.1

—

(40765096) Chromosome analysis panel by Banding

107

2.15

2.96

1.2

1.1

—

(4034850)

182

1409

1.30

2.95

9.8

8.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

109

2.11

2.84

1.0

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

223

1.75

2.81

1.3

1.4

92.0

675.4

titre

—

(3029075) Extractable nuclear Ab panel - Serum

124

2.02

2.75

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

5.01

2.72

1.0

—

(1761868) Lipid panel - Serum or Plasma

1756

16459

1.10

2.72

2.9

2.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

6.01

2.69

3.0

1.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

146

1.92

2.69

3.5

2.3

—

(4268621)

429

1.52

2.68

2.5

2.3

—

(3045788) Cell count panel - Pleural fluid

249

1.69

2.68

1.6

1.5

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

4.22

2.67

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

3.13

2.64

1.4

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

134

1012

1.33

2.63

1.2

1.3

1.0

2.5

u/ml

—

(3019977) pH of Arterial blood

155

1.88

2.60

3.2

3.1

7.4

0.55

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

127

1.97

2.59

3.3

2.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

4.67

2.59

1.1

327.3

284.9

nmol/l

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

163

1.85

2.57

1.9

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

163

1.85

2.57

1.9

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

330

1.58

2.56

1.2

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

160

1244

1.30

2.56

4.2

3.3

25.1

25.0

mmol/l

0.18

152

1156

(3004716) Salmonella sp identified in Stool by Organism specific culture

289

2406

1.21

2.55

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

193

1.77

2.53

3.3

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

193

1.77

2.53

3.3

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

193

1.77

2.53

3.3

1.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

393

4567

0.85

2.52

1.6

1.7

—

(3006270) Folate [Moles/volume] in Blood

332

1.57

2.50

1.1

415.7

385.5

nmol/l

0.47

298

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

194

1.76

2.50

3.3

1.8

—

(3001186) Copper [Moles/volume] in Serum or Plasma

2.11

2.48

1.6

1.3

16.3

17.5

umol/l

0.78

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

4.38

2.47

6.6

12.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.82

2.47

5.7

6.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

302

1.59

2.46

3.9

4.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

358

1.54

2.45

1.3

1.1

33.0

34.4

mg/l

0.15

301

(3015183) Erythrocyte sedimentation rate

256

1.65

2.44

1.1

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

166

1.81

2.44

1.8

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.55

2.44

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

486

4252

1.16

2.41

4.1

4.0

24.1

21.3

3.03

225

2001

(3034426) Prothrombin time (PT)

145

1.87

2.41

1.3

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

5.00

2.40

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

894

0.68

2.39

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1220

0.72

2.39

1.4

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

385

1.51

2.37

5.3

4.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

125

1.92

2.35

3.0

4.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

118

1.95

2.35

5.6

3.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

476

1.46

2.34

1.1

—

4.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

346

1.54

2.34

1.2

1.1

215.9

225.6

mg/l

0.22

302

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

214

1.69

2.31

1.3

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

207

2530

0.81

2.31

1.4

1.5

—

(3001556) Androgen free Index in Serum or Plasma

2.69

2.27

2.1

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

208

1.69

2.26

1.2

1.1

1609.0

1476.7

miu/ml

0.29

208

(40758292) HTLV I+II Ab panel - Serum

2.28

2.24

1.7

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

5.56

2.21

3.8

2.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

157

1.79

2.21

2.0

2.6

178.3

166.1

umol/l

0.06

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

499

1.43

2.21

1.1

1.5

g/l

0.09

450

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

107

1.97

2.20

1.1

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

320

1.54

2.18

1.5

1.4

1476.7

2865.7

e6/l

1.47

233

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.50

2.18

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

282

1.57

2.13

1.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

282

1.57

2.13

1.3

1.1

1.0

ratio

1.05

(3004775) Volume in Urine collected for unspecified duration

235

1.62

2.13

2.3

613.7

650.2

0.22

160

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

212

1.66

2.12

1.1

1.0

96.3

89.6

0.69

162

(3014891) Appearance of Pleural fluid

2.71

2.10

1.7

1.6

—

(3008898) HLA-B27 [Presence]

218

1804

1.22

2.10

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

119

918

1.30

2.08

1.8

1.7

7980.9

10777.0

e6/l

0.57

672

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

158

1264

1.26

2.08

1.3

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.18

2.04

1.7

2.4

8.3

7.0

mmol/l

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

141

1.78

1.96

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

175

2134

0.81

1.96

1.5

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

4.55

1.94

1.0

3.4

2.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

164

1.71

1.94

1.3

1.4

101.4

251.9

pmol/l

0.38

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.75

1.93

1.0

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

294

2525

1.17

1.91

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

100

766

1.31

1.87

2.9

3.4

1536.3

759.0

u/ml

0.34

699

(3028433) Virus identified in Specimen by Culture

136

1.77

1.86

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.21

1.84

1.4

1.5

—

(40757373) Influenza virus identified in Isolate

2.21

1.84

1.2

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

253

1.55

1.83

1.1

1.4

1.1

1.3

promille

0.40

195

(3038177) Helicobacter pylori Ab [Presence] in Serum

106

822

1.30

1.82

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.17

1.82

3.8

3.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

160

1.69

1.81

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

427

1.41

1.80

1.1

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.05

1.80

1.4

2.0

70.1

49.6

umol/l

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.00

1.79

1.2

1.0

—

(3022475) Manganese [Moles/volume] in Blood

2.76

1.79

1.1

1.4

—

(4038314)

3.85

1.71

1.0

1.2

—

(3022689) Creatine [Moles/volume] in Urine

1.88

1.70

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

282

0.53

1.70

1.2

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

556

1.34

1.62

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

352

1.42

1.62

1.3

1.4

12.7

12.4

mmol/l

0.07

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.15

1.61

3.2

2.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.33

1.60

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

312

1.45

1.58

3.2

2.5

21.6

36.9

mg/l

0.31

216

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

769

1.28

1.58

1.5

1.8

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.82

1.57

2.5

1.3

—

(3014271) Vancomycin [Susceptibility]

129

1.71

1.56

3.2

2.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

183

1540

1.20

1.56

2.5

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

160

1.63

1.55

3.7

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

160

1.63

1.55

3.7

2.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

322

1.43

1.55

1.1

11.0

9.8

iu/ml

0.09

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

163

1358

1.21

1.54

1.5

1.3

—

(4024509)

433

0.64

1.54

1.7

1.6

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.59

1.51

11.9

4.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.86

1.50

8.0

6.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

634

1.30

1.50

1.9

2.2

5.9

5.5

umol/l

0.14

460

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.90

1.49

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

162

1.61

1.49

3.7

2.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

418

1.37

1.48

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

147

1.64

1.47

1.3

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.50

1.45

1.1

1.2

—

(40761535) Cells panel - Urine sediment

366

3267

1.13

1.45

4.2

3.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

571

5225

1.10

1.45

1.6

1.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

140

1.65

1.44

1.3

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.12

1.44

1.1

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

286

1.44

1.42

1.6

1.4

35275.1

74698.9

e6/l

0.67

164

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

526

1.32

1.41

1.9

1.4

—

(40768441) Liver Pathology biopsy report

304

1.42

1.40

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

304

1.42

1.40

2.5

2.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.18

1.39

3.8

2.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.42

1.39

2.7

3.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

263

1.45

1.38

1.6

1.4

13.4

7.4

ug/l

0.44

228

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.94

1.36

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

165

1398

1.19

1.34

2.0

1.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

159

1.58

1.34

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

570

0.72

1.33

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

266

1.43

1.31

4.9

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.50

1.30

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

275

1.42

1.30

1.2

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

129

1.63

1.29

1.3

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

528

5745

0.91

1.28

2.0

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

447

1.32

1.28

1.7

1.5

—

1160.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.78

1.28

1.0

1.1

—

(3012441) Differential panel - Pleural fluid

268

1.42

1.27

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

362

1.36

1.26

4.5

3.4

58.5

55.3

0.44

249

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.40

1.24

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

253

0.59

1.23

2.4

1.8

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

163

1.54

1.22

1.0

1.1

128.2

321.1

ng/l

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.63

1.21

2.0

1.5

—

0.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.63

1.21

1.6

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

513

1.29

1.21

1.9

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1051

0.81

1.19

1.7

—

(3019225) pH of Specimen

444

4059

1.10

1.19

8.6

3.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.31

1.18

1.5

1.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.11

1.18

2.1

1.9

1.3

1.4

umol/l

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

165

1.52

1.17

1.1

—

(40768806) Pleura Pathology biopsy report

290

1.38

1.17

1.6

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

1.16

0.0

1.0

—

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.05

1.15

1.0

1.1

—

(3022621) pH of Urine by Test strip

303

2719

1.12

1.15

3.4

2.8

—

(3048879) Bone marrow aspiration report

1.73

1.15

5.8

2.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

115

1370

0.84

1.13

1.3

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

807

1.22

1.12

1.1

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

2.26

1.10

2.7

3.1

20.9

22.0

mg/l

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

2.26

1.10

1.1

1.4

76.5

68.6

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

176

1.48

1.10

1.3

1.6

—

1273502.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

202

1773

1.14

1.10

1.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

115

1365

0.84

1.09

1.3

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

513

1.27

1.09

1.9

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

539

4996

1.09

1.08

1.5

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

152

1.52

1.08

1.3

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

116

1372

0.84

1.06

1.3

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.76

1.06

1.1

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

281

3122

0.89

1.06

1.3

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

391

3576

1.10

1.06

1.7

1.8

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

116

1371

0.84

1.06

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

516

1.26

1.04

1.9

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

806

1.21

1.03

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.06

1.02

1.1

53.2

1.7

umol/24h

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.84

1.02

1.0

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

518

1.26

1.02

1.9

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

146

1687

0.86

1.02

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.69

1.01

1.4

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.69

1.01

1.4

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.69

1.01

1.4

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.88

1.00

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.62

0.99

1.4

1.3

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.62

0.99

1.8

1.4

36.2

39.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

520

1.25

0.99

1.9

1.4

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.71

0.98

1.2

1.4

—

110.9

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

2.17

0.98

3.0

1.7

26.2

62.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

190

1677

1.14

0.98

1.4

1.3

221.8

229.6

miu/ml

0.11

843

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

4.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.63

0.97

1.0

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

474

5106

0.92

0.97

1.9

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

469

1.26

0.96

1.6

1.7

51.1

53.7

0.15

294

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.78

0.94

3.3

5.6

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.78

0.94

1.6

2.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

125

1.52

0.93

1.1

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

127

1471

0.86

0.93

1.4

1.5

—

(4198724)

158

1.46

0.93

1.7

1.8

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.82

0.92

1.4

1.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.07

0.89

1.2

1.0

7.5

18.0

u/l

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.69

0.88

1.2

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

484

0.76

0.88

1.6

2.1

27.3

23.3

mg/l

—

134

(3017732) Neutrophils [#/volume] in Blood

341

3135

1.09

0.87

2.4

2.6

4.3

4.0

e9/l

1.35

278

2526

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

161

1.43

0.86

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

240

0.67

0.85

8.8

12.1

538.2

868.6

nmol/l

1.98

229

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.59

0.84

1.0

1.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

154

1.43

0.83

2.0

159.5

152.1

0.16

140

(3025018) Bordetella pertussis Ab [Titer] in Serum

292

1.30

0.82

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

1.69

0.82

2.1

1.8

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

330

0.73

0.81

1.3

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1055

10118

1.05

0.81

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.61

0.81

5.5

2.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.61

0.81

5.4

2.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

101

1172

0.86

0.79

1.4

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

305

2804

1.09

0.79

1.5

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

173

1.39

0.78

1.0

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

238

2168

1.10

0.76

1.5

1.4

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.76

0.0

1.0

—

0.7

—

(3024869) Neuronal Ab [Presence] in Serum

1.70

0.75

1.1

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

116

1013

1.15

0.75

1.5

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1133

0.86

0.75

1.4

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

244

0.70

0.75

10.6

17.3

974.7

5365.3

nmol/l

0.59

236

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.08

0.74

1.0

1.2

—

(3005033) Fetal Nuchal fold Thickness US

1131

0.86

0.73

1.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.00

0.72

3.0

1.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

362

1.25

0.71

1.5

1.6

48.8

35.1

1.06

217

(3019174) dRVVT (LA screen)

1.75

0.71

1.1

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.92

0.70

2.8

1.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

844

1.15

0.68

3.3

27.8

25.0

mg/l

0.30

506

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

714

1.17

0.67

1.1

—

(3002619) Bacteria identified in Specimen by Culture

0.54

0.67

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

103

1.46

0.64

1.8

1.2

—

(40768793) Breast Pathology biopsy report

149

1343

1.11

0.62

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

173

1.33

0.61

1.1

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.57

0.60

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.57

0.60

6.5

3.1

—

(3051101) Glucose [Moles/volume] in Cord blood

1.51

0.58

3.6

5.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.51

0.58

1.1

1.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

1.46

0.58

1.2

1.1

79.0

81.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.48

0.57

5.1

7.6

—

(44813793)

343

1.20

0.50

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

302

0.79

0.49

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

246

0.77

0.49

1.8

1.7

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.52

0.48

2.9

2.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.49

0.47

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.43

0.46

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

330

0.82

0.44

1.1

1.0

0.5

0.9

u/ml

0.65

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.37

0.44

1.1

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

148

1.28

0.43

1.0

1.1

92.2

94.9

0.14

(44816559) Phosphatidylethanol [Mass/volume] in Blood

735

1.12

0.43

1.1

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

632

1.13

0.42

1.3

7.2

mmol/l

0.02

477

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

330

3138

1.06

0.41

2.9

0.7

ug/l

1.08

231

1993

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

2.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

150

1.27

0.40

1.1

85.3

91.8

0.48

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.6

—

24.7

—

(3042517) Benzodiazepines panel - Urine

1.43

0.39

1.8

2.9

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

516

4970

1.04

0.39

1.5

1.7

1.4

0.26

469

4443

(3047007) Chlamydophila sp Ab [Presence] in Serum

703

1.11

0.38

1.3

1.2

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.39

0.38

1.0

1.1

—

3.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.33

0.35

1.3

1.1

69.9

74.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.33

0.33

1.2

1.4

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.33

0.33

8.2

3.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

777

1.10

0.33

1.3

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.67

0.33

1.8

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

285

0.84

0.32

1.4

—

(3038026) Centromere Ab [Units/volume] in Serum

370

0.86

0.32

1.2

—

57.3

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

1.31

0.31

1.1

1.3

99.6

108.1

0.46

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

100

925

1.08

0.31

1.6

1.4

30.9

28.6

u/l

0.23

765

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

193

1828

1.06

0.31

1.9

1.7

4.6

3.6

mg/l

0.54

147

1265

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

211

1.19

0.31

1.6

2.0

—

(3024263) Appearance of Synovial fluid

193

1.19

0.30

1.4

1.8

—

(44806420)

1.33

0.30

2.1

2.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.31

0.30

1.9

2.1

11.5

15.6

umol/l

1.08

(3007916) DNA double strand Ab [Titer] in Serum

1.29

0.28

1.8

1.4

—

150.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

117

1096

1.07

0.28

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

206

1.17

0.26

2.2

1.7

2.1

3.9

u/field

0.76

141

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

106

993

1.07

0.26

1.1

1.7

1.1

u/ml

0.21

377

(3020650) Glucose [Presence] in Urine

123

1.22

0.25

1.3

1.5

—

(3051593) INR in Capillary blood by Coagulation assay

126

0.79

0.24

11.3

11.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

323

1.12

0.22

1.1

0.8

2.2

u/ml

0.55

(3044009) aPTT.lupus sensitive (LA screen)

1.25

0.22

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

155

1624

0.95

0.22

1.7

1.9

—

(3006462) Nitrate [Presence] in Urine

199

0.85

0.21

2.3

3.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.19

0.21

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3036180) Methadone [Presence] in Urine

0.00

0.21

0.0

3.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.21

0.0

2.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

377

0.90

0.21

1.6

—

(3007456) Orange IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

838

1.06

0.20

1.1

1.6

1.8

u/ml

0.07

196

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

12.5

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

108

1.20

0.20

1.1

89.5

54.6

u/ml

0.59

102

(3037556) Urate [Mass/volume] in Serum or Plasma

111

0.81

0.20

1.0

1.4

—

(3045424) Erythrocytes [Presence] in Urine

713

1.07

0.20

1.6

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

109

1.19

0.18

1.1

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

204

1.13

0.18

1.1

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

300

0.90

0.18

1.1

1.0

0.2

2.1

u/ml

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.21

0.17

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

310

0.90

0.17

1.1

1.2

—

(4146454)

310

1.10

0.17

2.9

2.5

—

(3028707) Methadone [Presence] in Urine by Screen method

718

1.06

0.17

1.8

2.9

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

340

0.91

0.16

1.2

—

5.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

226

1.11

0.15

1.0

737.4

746.2

ng/l

0.03

147

(3003888) Timothy IgE Ab [Units/volume] in Serum

898

1.05

0.15

1.0

1.1

3.6

5.4

u/ml

0.76

461

(3009466) Valproate [Moles/volume] in Serum or Plasma

480

1.06

0.13

4.7

5.2

339.8

372.5

umol/l

1.06

413

(3020491) Glucose [Moles/volume] in Blood

276

1.09

0.13

1.7

1.9

7.2

6.4

mmol/l

0.51

190

(3010144) Erythrocytes [#/volume] in Synovial fluid

354

1.07

0.13

1.5

1.4

49999.7

40209.6

e6/l

0.09

245

(4133840)

109

0.83

0.13

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

1.18

0.12

1.0

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.18

0.12

1.0

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.18

0.12

1.0

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.18

0.12

1.0

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

229

1.09

0.12

1.0

38.7

48.5

ng/l

0.58

151

(3041806) Other cells [#/volume] in Blood by Manual count

143

1.12

0.11

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

126

0.87

0.11

2.2

3.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

126

0.87

0.11

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

859

1.04

0.10

1.0

1.1

1.2

1.1

u/ml

0.03

357

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.06

0.09

1.0

—

(4211845)

217

0.92

0.09

3.4

3.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

685

0.96

0.09

1.1

2.1

3.4

u/ml

0.71

266

(3014051) Protein [Presence] in Urine by Test strip

952

1.03

0.08

1.8

1.9

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.05

0.08

1.0

1.1

—

(44806071)

1.05

0.08

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

112

1149

0.97

0.08

1.8

3.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

224

1.07

0.08

1.0

246.8

356.7

ng/l

1.36

152

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.82

0.07

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

112

0.89

0.07

1.4

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.83

0.07

1.4

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

170

1674

1.02

0.06

1.6

2.1

—

(3016879) Cocaine [Presence] in Urine

152

1545

0.98

0.06

1.6

2.2

—

(3045414) Leukocytes [Presence] in Urine

191

1936

0.99

0.05

1.8

—

(3044007) Cell count panel - Peritoneal fluid

1.11

0.05

3.1

1.8

—

(3019832) Treponema pallidum Ab [Presence] in Serum

463

4666

0.99

0.05

1.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

111

1.08

0.04

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

127

1287

0.99

0.04

1.7

2.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

129

0.93

0.03

1.3

1.6

9.3

8.1

ug/l

0.39

129

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

149

0.94

0.03

1.0

—

5.3

—

(3004616) Nuclear Ab [Presence] in Serum

570

0.98

0.02

1.3

—

(3027944) Amphetamines [Presence] in Urine

168

1667

1.01

0.02

1.6

2.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

610

0.98

0.02

1.1

2.2

0.3

u/ml

0.42

129

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

113

1.06

0.01

1.1

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

114

1.05

0.00

1.1

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

503

5038

1.00

0.00

7.7

5.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

474

1.01

0.00

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

734

1.01

0.00

1.1

5.1

3.2

u/ml

0.39

268

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

104

0.96

0.00

1.1

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

144

0.97

0.00

2.0

2.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

113

0.97

0.00

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

326

1.01

0.00

1.2

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

373

0.99

0.00

1.5

7.7

mmol/l

0.04

234

(3028300) Cannabinoids [Presence] in Urine

169

1693

1.00

0.00

1.6

2.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

301

1.00

0.00

3.1

2.0

4.2

2.3

u/field

—

122

(3027008) Opiates [Presence] in Urine

169

1689

1.00

0.00

1.6

2.1

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

0.00

0.0

1.6

—

66.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(4015189)

0.92

0.00

2.4

2.6

—

(3033799) Differential panel - Peritoneal fluid

1.01

0.00

3.6

1.9

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.3

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.00

0.00

1.2

1.4

15.8

28.6

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

0.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.92

0.00

1.6

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.2

—

66.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.2

—

40.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

5.3

—

0.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

240

1.00

0.00

1.3

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

4.4

—

(3000285) Sodium [Moles/volume] in Blood

1.00

0.00

1.8

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.00

0.00

1.2

1.1

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

0.91

0.00

1.5

1.4

35.0

24.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_ENDOMETPOSTOP and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_ENDOMETPOSTOP	1.389 [1.25, 1.54]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.251

During the follow-up period (1.1.1998 — 31.12.2019), 2313 out of 15139 females with E4_ENDOMETPOSTOP died.

Males

Parameter	HR [95% CI]	p-value
E4_ENDOMETPOSTOP	1.759 [1.53, 2.02]	< 0.001
Birth year	0.982 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 856 out of 3787 males with E4_ENDOMETPOSTOP died.

Mortality risk

Mortality risk for people of age

years, who have E4_ENDOMETPOSTOP.

N-year risk	Females	Males
1	0.106%	0.304%
5	0.716%	1.862%
10	2.022%	4.208%
15	3.956%	8.218%
20	6.946%	13.828%

Relationships between endpoints

↥

Index endpoint: E4_ENDOMETPOSTOP – Postprocedural endocrine and metabolic disorders, not elsewhere classified

GWS hits: 7

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Postprocedural endocrine and metabolic disorders, not elsewhere classified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints